Hemodialysis equipment
By using the metabolic filtration module in the hemodialysis equipment to intercept enzymes and process them through the adsorption device, the problems of low exchange efficiency and enzyme shedding in the existing adsorption dialysis system are solved, and efficient dialysate regeneration and safety improvement are achieved.
Patent Information
- Application Number
- CN202411321562.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-12-09
- Filing Date
- 2023-11-16
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2043-11-16
AI Technical Summary
The exchange efficiency in existing adsorption dialysis systems is low, resulting in increased enzyme usage, loss of efficiency and safety risks, and high cost of consumables.
Design a hemodialysis device, including purification circuits, dialysis devices, metabolic filtration modules and adsorption devices, and recycle liquid is generated through the metabolic filtration module to improve exchange efficiency and reduce the risk of enzyme shedding.
It effectively reduces the amount of enzyme, improves dialysis efficiency, reduces safety risks, and reduces consumables costs, achieving efficient operation of the dialysate regeneration circulation system.
Smart Images

Figure CN119055867A_ABST
Abstract
Description
[0001] This application is a divisional application filed in accordance with Article 48 of the Implementing Regulations of the Patent Law. The parent case is international application number PCT / CN2023 / 131926, with an international application date of November 16, 2023, a priority date of December 9, 2022, a priority number of 202211584213.4, and a date of entry into the Chinese national phase of April 18, 2024. The national application number is 202380014058.9. The name of the invention is dialysate regeneration circulation system and dialysis equipment. The applicant is Shanghai Xinguang Biomedicine Co., Ltd.'s Chinese invention application. All the contents of the parent case of this application are fully cited in this application. Technical Field
[0002] The present application relates to the technical field of medical devices, and in particular to a dialysate regeneration circulation system and a hemodialysis device used in the dialysis field. Background Art
[0003] The Sorbent Dialysis system was first developed by NASA for the recycling of astronauts' urine. In 1973, the first commercial model, the REDY Machine (Regeneration of dialysate), achieved great commercial success. Between 1973 and 1994, the REDY system successfully implemented 6 million hemodialysis treatments, most of which were performed at home, proving its good convenience, safety and clinical value. However, the Achilles' heel of adsorption dialysis is that the consumables are extremely expensive, the professional training for production and maintenance is extremely strict, and the early systems contain biotoxic materials such as aluminum, which eventually led to its gradual elimination from the market by the Single Pass type (the currently widely used traditional dialysis machine).
[0004] In traditional adsorption dialysis, urease is mainly used to process urea. Uremic patients have lost their kidney function, so toxins will accumulate in the body, including urea. Since the body's protein will be converted into urea after metabolism and excreted through the kidneys, the urea content of uremic patients is often very high, around 20mM.
[0005] Urea molecules are highly polar and easily soluble in water, so traditional adsorbents are basically unable to adsorb urea, or have extremely poor selectivity or extremely high costs. Early scientists used urease to decompose urea to produce carbon dioxide and ammonia, and then adsorbed ammonia through zirconium phosphate. Traditional urease is loaded on aluminum oxide microspheres and filled in the adsorption column. Liquid is perfused in, and urea is decomposed after enzyme treatment (not all decomposition is required). Due to the extremely high urea content, the required enzyme dosage is also extremely high, and due to the unreliable adsorption, with the continuous flushing of the liquid, the urease falls off severely after one treatment and is deposited in the downstream adsorption column material, resulting in severe activity loss, resulting in the adsorption column and urease can only be used once, which greatly increases the amount and cost of urease in adsorption dialysis.
[0006] In the filling perfusion mode, urease is relatively fixed and the liquid flows through, so the probability of mutual collision is much lower than that in a homogeneous system or solution. The low exchange efficiency of the above mode increases the amount of enzyme to ensure the treatment effect. In previous patents, the amount of urease used was between 20,000U and 60,000U, which in turn increased the cost of consumables. The shedding of the enzyme will also lead to the loss of enzyme efficiency and safety risks. The cost of consumables is an important limiting factor for the commercial application of dialysate regeneration dialysis machines and the promotion of home hemodialysis. Summary of the invention
[0007] In view of the shortcomings of the related technologies mentioned above, the purpose of the present application is to provide a hemodialysis device to solve the problems of low exchange efficiency in the existing filling perfusion mode, which leads to increased enzyme usage, and enzyme efficiency loss and safety risks due to enzyme shedding.
[0008] To achieve the above-mentioned purpose and other related purposes, the present application provides a hemodialysis device, comprising: a purification circuit, comprising a first circuit whose input end is connected to a first part of a human body, and a second circuit whose output end is connected to a second part of a human body; a dialysis device, arranged on the purification circuit, for purifying a fluid flowing in the purification circuit, the dialysis device comprising a dialysate output end and a dialysate input end; a waste liquid passage, whose input end is connected to a dialysate output end of the dialysis device; a metabolic filtration module, connected to the waste liquid passage, for subjecting a mixed solution composed of dialysis waste liquid and enzymes or enzyme preparations or enzyme-loaded microspheres from the waste liquid passage to a first toxin treatment and then filtering out a metabolic treatment solution of the dialysis waste liquid; the metabolic filtration module comprising a separation component to separate the metabolic filtration The module is separated to form a first side for connecting to the waste liquid passage and a second side for filtering out the dialysis waste liquid metabolic treatment liquid, and the enzyme or enzyme preparation or enzyme-loaded microspheres are retained on the first side; an adsorption device, whose input end is connected to the second side of the metabolic filtration module, is used to perform a secondary toxin treatment on the dialysis waste liquid metabolic treatment liquid after the initial toxin treatment to generate a regeneration liquid; a regeneration liquid pipeline, whose inlet is connected to the adsorption device for outputting the regeneration liquid, and whose outlet is connected to the dialysis liquid input end of the dialysis device; a driving device, which is arranged on the first line and located in the purification circuit, and is used to drive the fluid to flow in the purification circuit; a control device, which is used to execute a treatment mode to purify the fluid flowing in the purification circuit and then input it into the human body.
[0009] In summary, the hemodialysis equipment provided by the present application adds a preparation such as enzyme-loaded microspheres to the metabolic filtration module, performs a first toxin treatment on the mixed liquid consisting of the dialysis waste liquid and the enzyme or enzyme preparation or enzyme-loaded microspheres from the waste liquid passage, and then filters out the dialysis waste liquid metabolic treatment liquid, and at the same time, the enzyme or enzyme preparation or enzyme-loaded microspheres are retained in the metabolic filtration module, and the treated liquid flows out of the metabolic filtration module through the metabolic filtration module, and is then treated by an adsorption device to produce a dialysis regeneration liquid, which is used again in the dialysis process after potassium, calcium and magnesium ions are supplemented in the regeneration liquid pipeline, thereby solving the problems of low exchange efficiency in the existing perfusion mode, which increases the amount of enzyme used, and the loss of enzyme efficiency and safety risks due to enzyme shedding. BRIEF DESCRIPTION OF THE DRAWINGS
[0010] The specific features of the present application are shown in the attached claims. The features and advantages of the invention involved in the present application can be better understood by referring to the exemplary embodiments and drawings described in detail below. The drawings are briefly described as follows:
[0011] Figure 1 Shown is a schematic diagram of the composition of a dialysate regeneration circulation system in one embodiment of the present application.
[0012] Figure 2Shown is a schematic diagram of a dialysate regeneration circulation system in one embodiment of the present application.
[0013] Figure 3 Shown is a schematic diagram of a dialysate regeneration circulation system according to another embodiment of the present application.
[0014] Figure 4 Shown is a schematic diagram of a metabolic cycle device of the present application in one embodiment.
[0015] Figure 5 Shown is a schematic diagram of the metabolic cycle device of the present application in another embodiment.
[0016] Figure 6 Shown is a schematic diagram of a metabolic cycle device of the present application in yet another embodiment.
[0017] Figure 7 Shown is a schematic diagram of a metabolic cycle device of the present application in yet another embodiment.
[0018] Figure 8 Shown is a schematic diagram of the metabolic cycle device of the present application in another embodiment.
[0019] Fig. 9 Shown is a schematic diagram of the composition structure of the hemodialysis device in one embodiment of the present application.
[0020] Fig.10 Shown is a schematic diagram of the composition structure of the hemodialysis device of the present application in another embodiment.
[0021] Fig.11 Shown is a schematic diagram of the composition architecture of the hemodialysis device of the present application in the pre-dilution mode.
[0022] Fig.12 Shown is a schematic diagram of the composition architecture of the hemodialysis device of the present application in the post-dilution mode.
[0023] Fig.13 Shown is a schematic structural diagram of an adsorption device of the present application in one embodiment.
[0024] Fig.14 Shown is a schematic structural diagram of the adsorption device of the present application in another embodiment.
[0025] Fig.15 Shown is a schematic structural diagram of the adsorption device of the present application in yet another embodiment.
[0026] Fig.16 Shown is a schematic structural diagram of the adsorption device of the present application in yet another embodiment.
[0027] Fig.17Shown is a structural diagram of an implementation of the adsorption device of the present application in a regeneration liquid circulation system.
[0028] Fig.18 Shown is a schematic diagram of the position of the substitution fluid branch of the hemodialysis device of the present application in the pre-dilution mode.
[0029] Fig.19 Shown is a schematic diagram of the position of the substitution fluid branch of the hemodialysis device of the present application in the post-dilution mode.
[0030] Fig.20a and Fig.20b It is a schematic diagram of the structure that the first metabolic circulation pump and the second metabolic circulation pump of the present application are arranged in parallel upstream or downstream of the metabolic filtration module.
[0031] Fig.21 Shown is a schematic cross-sectional structure diagram of a pneumatic fluid pump in one embodiment of the present application.
[0032] Fig.22a and Figure 22b Shown is a schematic structural diagram of a metabolic circulation device of the present application in one embodiment. DETAILED DESCRIPTION
[0033] The following is an explanation of the implementation of the present application by means of specific embodiments. People familiar with the art can easily understand other advantages and effects of the present application from the contents disclosed in this specification.
[0034] In the following description, with reference to the accompanying drawings, several embodiments of the present application are described. It should be understood that other embodiments may also be used, and mechanical composition, structure, electrical and operational changes may be made without departing from the spirit and scope of the present application. The following detailed description should not be considered restrictive, and the scope of the embodiments of the present application is limited only by the claims of the disclosed patents. The terms used here are only to describe specific embodiments and are not intended to limit the present application. Spatially related terms, such as "upper", "lower", "left", "right", "below", "below", "lower", "above", "upper", etc., may be used in the text to facilitate the description of the relationship between an element or feature shown in the figure and another element or feature.
[0035] Although the terms first, second, etc. are used to describe various elements or parameters in this article in some instances, these elements or parameters should not be limited by these terms. These terms are only used to distinguish an element or parameter from another element or parameter. For example, the first interface can be referred to as the second interface, and similarly, the second interface can be referred to as the first interface, without departing from the scope of the various described embodiments. The first interface and the second interface are both describing an interface, but unless the context clearly indicates otherwise, they are not the same interface. Similar situations also include the first communicating member and the second valve part, or the first communicating member and the second valve part.
[0036] Furthermore, as used in this article, the singular forms "one", "an" and "the" are intended to include plural forms as well, unless there is an indication to the contrary in the context. It should be further understood that the terms "comprise", "include" indicate the presence of the described features, steps, operations, elements, components, projects, kinds, and / or groups, but do not exclude the presence, occurrence or addition of one or more other features, steps, operations, elements, components, projects, kinds, and / or groups. The terms "or" and "and / or" used herein are interpreted as inclusive, or mean any one or any combination. Therefore, "A, B or C" or "A, B and / or C" means "any of the following: A; B; C; A and B; A and C; B and C; A, B and C". Exceptions to this definition will only occur when the combination of elements, functions, steps or operations is inherently mutually exclusive in some way.
[0037] The present application discloses a dialysate regeneration circulation system used in medical equipment, which is used to process dialysate waste generated during the dialysis process to generate regeneration fluid that is then input into the dialysis equipment or the human body.
[0038] In the present application, the medical equipment includes, but is not limited to, blood purification equipment, extracorporeal circulation removal system, extracorporeal enrichment and removal equipment, hemodialysis equipment, plasma exchange equipment, extracorporeal peritoneal dialysis equipment, or extracorporeal membrane oxygenation equipment. Among them, the blood purification equipment includes, but is not limited to, hemodialysis (HD), hemofiltration (HF), hemodiafiltration (HDF), hemoperfusion (HP), blood exchange (PE), immunoadsorption (IA) and continuous blood purification (CRRT), peritoneal dialysis (PD) and other equipment.
[0039] In other embodiments, the medical device may also be a component module grafted into other extracorporeal circulation devices, such as artificial liver, artificial kidney, hemodialysis equipment, peritoneal dialysis equipment, plasma exchange equipment, plasma purification equipment, blood lipid purification equipment, molecular adsorption recirculation system, extracorporeal membrane oxygenation equipment, leukocyte removal equipment, extracorporeal circulation life support system, etc. In certain embodiments, the medical device is used alone as a medical device or treatment device, and may also be integrated into other medical devices or instruments involving extracorporeal treatment of blood or other body fluids to form a new device.
[0040] In the present application, the "regeneration fluid" refers to the dialysate waste liquid after the dialysate is exchanged with blood or peritoneal fluid, and is treated with adsorbent materials and enzymes (e.g., catalytic decomposition and adsorption treatment) to remove some or most of the toxins or toxic molecules in the dialysate waste liquid, and supplemented with beneficial or necessary molecules such as potassium, calcium, and magnesium to form a dialysate waste liquid regeneration fluid, referred to as the regeneration fluid. The regeneration fluid can be regarded as fresh dialysate, which is exchanged with blood or peritoneal fluid again, and the cycle is repeated to continuously remove toxins in the blood or peritoneal fluid to achieve the purpose of treatment. The dialysis equipment using this dialysate circulation regeneration mode is called a dialysate regeneration type dialyzer, which includes a dialysate regeneration type hemodialysis machine and a dialysate regeneration type peritoneal dialysis machine. The biggest advantage of this type of dialyzer is that it does not require a water source and a water treatment system, so it is very small and portable, suitable for home hemodialysis and wearable dialysis equipment.
[0041] The dialysate regeneration circulation system of the present application includes a waste liquid passage, a metabolic circulation device, an adsorption device, and a regeneration liquid pipeline. Figure 1 , which is a schematic diagram showing the composition of a dialysate regeneration circulation system in one embodiment of the present application.
[0042] In the following embodiments, the dialysate regeneration circulation system is mainly used as an example for explanation in a blood purification device.
[0043] The input end 620 of the waste liquid passage L2-1 of the dialysate regeneration circulation system of the present application is connected to the outlet of the dialysate waste liquid; the output end of the waste liquid passage is connected to the metabolic circulation device 60, and the input end of the metabolic circulation device 60 is connected to the outlet of the waste liquid passage L2-1, which is used to metabolically circulate the input dialysate waste liquid for the first toxin treatment; the input end of the adsorption device 61 is connected to the output end of the metabolic circulation device 60, which is used to perform a secondary toxin treatment on the waste liquid after the first toxin treatment by the metabolic circulation device 60 to generate regeneration liquid; the inlet of the regeneration liquid pipeline L2-7 is connected to the adsorption device 61 for outputting the regeneration liquid. In an embodiment, a preparation such as enzyme-loaded microspheres can be added to the metabolic circulation device 60, and the preparation is circulated in the circulation pipeline by the driving device. Specifically, the dialysis waste liquid to be treated containing a high concentration of target molecules enters the metabolic circulation device 60 through the inlet, and the target molecule preparation is decomposed into corresponding products. The metabolic filtration module provided in the metabolic circulation device 60 continuously separates the treated liquid and retains the preparation in the metabolic circulation device 60. The treated liquid flows out of the metabolic circulation device 60 through the metabolic filtration module, and is then treated by the adsorption device to produce a dialysis regeneration liquid, which is used again in the dialysis process after potassium, calcium and magnesium ions are supplemented in the regeneration liquid pipeline L2-7.
[0044] See also Figure 2 , which is a schematic diagram of a dialysate regeneration circulation system of the present application in one embodiment.
[0045] In an embodiment of the dialysate regeneration circulation system applied to a blood purification device, the input end 620 of the waste liquid passage L2-1 is connected to a dialyzer to obtain the dialysate waste from the dialyzer. In an embodiment, the dialyzer is used to purify the blood flowing in the blood circuit, and forms a blood flow path for the patient's blood flow and a dialysate flow path for the dialysate flow through a built-in purification membrane for blood purification; in an embodiment, the dialyzer includes a dialysate chamber, a blood chamber and a semi-permeable membrane, etc., and the membrane separates the dialysate chamber and the blood chamber from each other. In the commonly used capillary dialyzer, the blood chamber is formed by the entire internal volume of the hollow fiber, and the dialysate chamber is formed by the inner cavity of the shell of the dialyzer surrounding the hollow fiber. In an embodiment, the top of the dialyzer is connected to the arterial blood line, and the bottom of the dialyzer is connected to the venous blood line. The types of dialyzers may include hemodialyzers, hemodiafiltration devices, hemofilters, plasma separators, blood plasma component separators and other devices of various specifications or uses. As long as the device can separate toxins or molecular components in the blood, the present application can be used.
[0046] The dialysate circuit includes a regeneration liquid pipeline L2-7 connected to the dialysate inlet of the dialyzer and a waste liquid passage L2-1 at the dialysate outlet, which are used to input the dialysate into the metabolic circulation device 60 and output it after treatment. It should be understood that the dialysate circuit also includes necessary valves, sensors and other necessary elements or components.
[0047] In an embodiment in which the dialysate regeneration circulation system is applied to a peritoneal dialysis device, the input end of the waste fluid passage L2 - 1 is connected to the human peritoneal cavity to obtain the dialysate waste from the human peritoneal cavity.
[0048] In one embodiment, the waste fluid passage L2-1 can be a pipeline conducted by a catheter. It should be understood that the "catheter" or "pipeline" disclosed in the present application means that the components can be fluidically connected to each other so as to provide a path for transferring fluid (i.e., saline, dialysate, etc.) between these components.
[0049] In another embodiment, compared with a home-use dialysis device or a portable dialysis device, based on the requirements of miniaturization of the overall volume of the dialysis device and compactness of the structure, the waste liquid passage L2-1 may adopt a flow channel, such as a flow channel formed by a plate or a closed guide groove. In some necessary structural designs, the flow channel may adopt a multi-layer structure with intervals and stacking.
[0050] In one embodiment, the input end 620 of the waste liquid passage L2-1 is provided with a dialysate outlet valve 621. Specifically, the dialysate outlet valve 621 may be a solenoid valve, an electrically switched valve, or a clamp for tightening the waste liquid passage L2-1 to close the waste liquid circulation.
[0051] In one embodiment, a leakage sensor 622 is provided in the waste liquid passage L2-1. In an embodiment in which the dialysate regeneration circulation system is applied to a blood purification device, the leakage sensor 622 is, for example, a blood leakage sensor for detecting blood leakage; in an embodiment in which the dialysate regeneration circulation system is applied to a peritoneal dialysis device, the leakage sensor 622 is, for example, a peritoneal fluid leakage sensor.
[0052] In one embodiment, a pressure sensor 6231' for detecting the pressure of dialysis waste liquid is provided on the waste liquid passage L2-1. A hydrophobic filter 6230 is provided between the waste liquid passage L2-1 and the pressure sensor 6231', and the permeability of the hydrophobic filter 6230 enables the pressure sensor 6231' to detect the waste liquid pressure in the waste liquid passage L2-1.
[0053] In one embodiment, the waste liquid passage L2-1 is connected to an ultrafiltration branch L2-2. In this embodiment, an ultrafiltration container 6242 for storing ultrafiltrate is provided on the ultrafiltration branch L2-2, and an ultrafiltration pump 6241 for transporting the ultrafiltrate in the ultrafiltration container 6242 to the waste liquid passage L2-1. An ultrafiltration filter 6240 may be provided between the ultrafiltration pump 6241 and the waste liquid passage L2-1. In one example, the ultrafiltration container 6242 is, for example, an ultrafiltration bag, for example, a liquid bag made of medical plastic; the ultrafiltration pump 6241 may be a plunger roller pump, a peristaltic pump or a diaphragm pump, etc.
[0054] In an embodiment where the dialysate regeneration circulation system is applied to a blood purification device, for example in a hemodialysis treatment mode (HD), that is, a standard normal treatment mode, since the exchange between molecules is a free exchange driven by concentration difference, the purpose of exchange and toxin removal is achieved. Since an ultrafiltration branch L2-2 is provided on the waste liquid passage L2-1, simultaneous ultrafiltration dehydration can bring about an additional amount (e.g., 3-4L) of transmembrane flow.
[0055] In one embodiment, when the dialysate regeneration circulation system is applied to the circulation of a blood purification device, the ultrafiltration pump 6241 will continuously extract the water in the waste liquid passage L2-1 to form a transmembrane negative pressure. At this time, the dialyzer will ultrafilter more water to achieve pressure balance. Ultimately, the blood loses as much water as the ultrafiltration pump 6241 extracts, thereby achieving the purpose of helping the human body remove excess water. In an actual embodiment, the ultrafiltration pump 6241 continuously extracts the dialysate waste in the waste liquid passage L2-1 into a waste liquid bag. By accurately measuring the flow rate of the ultrafiltration pump 6241, the excess water in the patient's body can be accurately extracted from the body, thereby achieving the purpose of dehydration.
[0056] In another embodiment, the ultrafiltration branch L2-2 can also be arranged on the regeneration liquid pipeline L2-7, that is, the ultrafiltration branch L2-2 includes a first ultrafiltration branch and a second ultrafiltration branch, wherein the first ultrafiltration branch is arranged on the waste liquid channel, and the second ultrafiltration branch is arranged on the regeneration liquid pipeline L2-7. In this embodiment, weighing ultrafiltration control is adopted, that is, dual pump control of an upstream pump and a downstream pump is adopted, wherein the upstream pump is arranged on the first ultrafiltration branch, and the downstream pump is arranged on the second ultrafiltration branch in the regeneration liquid pipeline L2-7, and the second ultrafiltration branch is connected to the second ultrafiltration branch. The container connected to the filter branch, such as an ultrafiltration bag, contains treated dialysis regeneration fluid. There is a weighing device under the ultrafiltration bag. The weighing device can obtain the content of the regeneration fluid in the ultrafiltration bag by weighing, and adjust the speed of the upstream pump and the downstream pump by controlling the speed. For example, if the water in the ultrafiltration bag exceeds the preset value (ultrafiltration curve), it means that more water has been ultrafiltrated, so the speed of the upstream pump is lowered and the speed of the downstream pump is increased. On the contrary, if the water in the ultrafiltration bag is lower than the preset value (ultrafiltration curve), the speed of the upstream pump can be increased and the speed of the downstream pump can be lowered.
[0057] In one embodiment, a preformed liquid bypass L2-3 is provided on the waste liquid passage L2-1 for prefilling, emptying, or flushing the circulation passage of the dialysate regeneration circulation system. In this embodiment, a short-circuit valve 626 is provided on the waste liquid passage L2-1 in parallel with the preformed liquid bypass L2-3.
[0058] In one embodiment, the preformed liquid bypass L2-3 is a system for prefilling and emptying the purification circuit, which is connected to a liquid storage container (e.g. Figure 2 The prefabricated liquid bag 625 shown, for example, is a liquid bag made of medical plastic), and cooperates with the working mode of the driving device, or the upright or inverted state of the liquid storage container to realize the two operations of pre-filling and emptying, that is, in the pre-filling mode, the outlet of the liquid in the liquid storage container is at a low position; and in the emptying mode, the outlet of the gas in the liquid storage container is at a high position; compared with the conventional operation in the prior art, the system of the present application has a simple structure, convenient operation, and low learning cost. The operator does not need to repeatedly invert the dialyzer for continuous circulation pre-filling. Furthermore, the application of the system of the present application enables more scientific treatment of medical waste such as pipelines and waste liquids after emptying.
[0059] In this embodiment, the system for pre-filling and emptying the purification circuit includes a liquid storage container (i.e. Figure 2 The prefabricated liquid bag 625 shown in FIG. 1 ), the circulation loop (i.e. Figure 2 The circulation loop composed of the waste liquid passage L2-1 and the regeneration liquid pipeline L2-7), and the driving device (i.e. Figure 2The dialysate pump 627) wherein the liquid storage container is used to store the pre-filled liquid and recover the emptied waste liquid, and comprises a container body, and a first interface and a second interface provided on the container body for serving as the inlet and outlet of liquid and / or gas; the first interface or the second interface is the inlet and outlet of the fluid in the container body. For example, the first interface and the second interface are Figure 2 The first interface b1 and the second interface b2 of the prefabricated fluid bag 625 are shown in FIG.
[0060] In this embodiment, the liquid storage container can be switched between upright and inverted states, that is, the state of placing the liquid storage container upright is upright, and the state of placing the liquid storage container upside down is inverted. In order to switch between the two states more simply, a mechanism for placing the liquid storage container upright or inverted is also included. In one embodiment, the mechanism is, for example, a plate or a frame for placing the liquid storage container, and a structure for fixing the liquid storage container and a positioning structure for positioning the upright state and the inverted state are provided on the plate or the frame, so that the liquid storage container can be stabilized in the upright state when it is placed upright, or can be stabilized in the inverted state when it is inverted.
[0061] In this embodiment, the system of the liquid storage container in the pre-filling and emptying purification circuit has two working modes, that is, in the pre-filling mode, the outlet of the liquid in the liquid storage container is at a low position; in the emptying mode, the outlet of the gas in the liquid storage container is at a high position; for example, in the pre-filling mode, the second interface is at a lower height so that the pre-filled liquid in the liquid storage container preferentially enters the pipeline in the circulation loop from the second interface, while in the emptying mode, the first interface is at a higher height so that the gas / bubble in the liquid storage container preferentially enters the pipeline in the circulation loop from the first interface. In the present application, the switching between the pre-filling mode and the emptying mode can be achieved by adjusting the flow direction of the fluid and / or switching the liquid storage container to be upright or inverted.
[0062] In some embodiments, the pre-liquid bypass is, for example, a system for pre-filling and emptying a purification circuit as described in patent document CN2022108507945; in the present application, the full text of patent document CN2022108507945 is cited herein.
[0063] In one embodiment, if Figure 1 and Figure 2As shown, a dialysate pump 627 is provided on the waste liquid passage L2-1, which is used to drive the fluid in the waste liquid passage L2-1 to flow forward or reversely. In this embodiment, when the dialysate pump 627 rotates forward, it is used to drive the dialysis waste liquid in the waste liquid passage L2-1 to flow to the downstream metabolic circulation device 60; when the dialysate pump 627 rotates reversely, it is used to drive the reverse flow in the waste liquid passage L2-1, such as in the working mode in which the prefabricated liquid bypass L2-3 needs to be flushed or emptied. The dialysate pump 627 includes a peristaltic pump, a diaphragm pump, a gear pump, and the like, which are driving pumps for driving the flow of liquid.
[0064] In one embodiment, a first dialysate pump is provided on the waste liquid passage, and a second dialysate pump is provided on the regeneration liquid pipeline, for changing the total amount of liquid equilibrium state of the dialysate regeneration circulation system by the differential speed of the first dialysate pump and the second dialysate pump; see Figure 3 , which is a schematic diagram of the dialysate regeneration circulation system of the present application in another embodiment, wherein a second dialysate pump 627' is also provided on the regeneration liquid pipeline L2-7, which drives the flow of the entire dialysate circulation in the same direction and flow rate as the first dialysate pump 627' on the waste liquid passage L2-1. This design can significantly reduce the pressure of the adsorption device 61. In some embodiments, the speeds of the first dialysate pump 627' and the second dialysate pump 627" are different to increase or decrease the solution volume of the metabolic cycle and / or the adsorption device 61 to achieve controllable and measurable ultrafiltration or filtration, wherein to achieve ultrafiltration, additional weighing or volume detection methods are often required to determine the ultrafiltration amount, wherein when periodic blood filtration is achieved, the difference in the rotation speeds of the two pumps is often periodic, or dynamically adjusted with the filtration amount or pressure.
[0065] In one embodiment, a temperature control device 628' is provided on the waste liquid passage L2-1 to control the temperature of the fluid in the waste liquid passage L2-1 to a preset range.
[0066] In another embodiment, a temperature control device 628" is provided on the regeneration liquid pipeline L2-7 for controlling the temperature of the fluid in the regeneration liquid pipeline L2-7 to a preset range.
[0067] exist Figure 3 In the embodiment shown, the waste liquid passage L2-1 and the regeneration liquid pipeline L2-7 are respectively provided with temperature control devices (628', 628"). In the above embodiment, the temperature control device is a heating device or a constant temperature device.
[0068] In one embodiment, a sample adding device (not shown) is provided on the waste liquid passage L2-1 for adding enzyme preparation (enzyme-carrying microspheres containing urease) to allow it to enter the metabolic circulation device 60. In this embodiment, the sample adding device is, for example, an opening or an injection port provided on the waste liquid passage L2-1.
[0069] In another embodiment, the sample adding device may also be disposed on the collecting container 600 of the metabolic circulation device 60 .
[0070] In the embodiment, the enzyme-loaded microspheres are microspheres immobilized with urease, with a size between 1-1000um, preferably 20-50um, and are not limited to the material or immobilization process of the microspheres. The enzyme-loaded microspheres are generally injected into the collection container in the form of a solution before treatment and then enter the circulation.
[0071] The metabolic circulation device 60 is a universal, platform-type device. When different enzyme preparations (enzyme-carrying microspheres) are added, different molecules can be removed, or different catalytic decomposition or synthesis effects can be played. For example, adding ethanol oxidase microspheres can oxidize ethanol, urate oxidase microspheres can oxidize uric acid, and phenylalanine ammonia lyase microspheres can decompose phenylalanine. Therefore, in theory, as long as there are enzymes with corresponding decomposition or synthesis functions, the concentration of the dialysis waste liquid as any target molecule can be changed, and then the concentration of the blood as the target molecule can be changed to achieve the purpose of treatment.
[0072] In one embodiment, the enzyme or enzyme preparation or enzyme-carrying microsphere in the metabolic cycle is in a flowing state. Specifically, the enzyme or enzyme preparation or enzyme-carrying microsphere added in the metabolic cycle device 60 flows with the circulating liquid participating in the circulation in the metabolic cycle device 60, wherein any liquid flowing in the metabolic cycle device 60 is the circulating liquid, and the circulating liquid is exemplified by the dialysis waste liquid to be treated, the dialysis waste liquid treated at least once, etc. In this way, the enzyme or enzyme preparation or enzyme-carrying microsphere can be evenly distributed in the metabolic cycle pipeline through circulation, thereby solving the problem of decreased metabolic effect caused by aggregation of the enzyme or enzyme preparation or enzyme-carrying microsphere, and improving the utilization rate of the enzyme or enzyme preparation or enzyme-carrying microsphere. In one embodiment, the flow rate of the circulating liquid in the metabolic cycle is greater than the flow rate of the liquid in the waste liquid passage or the regeneration liquid pipeline. In one example, the flow rate of the circulating liquid in the metabolic cycle is 4 to 7 times the flow rate of the liquid in the waste liquid passage or the regeneration liquid pipeline. For example, the flow rate of the liquid in the waste liquid passage or the regeneration liquid pipeline is 500 ml / min, and the flow rate of the circulating liquid in the metabolic cycle is 2000 ml / min. In this way, the circulating liquid can be rapidly circulated in the circulation device for multiple filtrations. It should be noted that, although the example in which the flow rate of the circulating liquid in the metabolic cycle is greater than the flow rate of the liquid in the waste liquid passage or the regeneration liquid pipeline is used for explanation, it is not limited to this. In other embodiments, the flow rate of the circulating liquid in the metabolic cycle may also be equal to the flow rate of the liquid in the waste liquid passage or the regeneration liquid pipeline.
[0073] In one embodiment, the first toxin treatment of the metabolic circulation device 60 is to remove urea from the dialysis waste liquid by adding enzymes or enzyme preparations or enzyme-loaded microspheres. In this application scenario, it is mainly aimed at patients with renal dysfunction or renal failure, or patients undergoing peritoneal dialysis or hemodialysis treatment.
[0074] When the metabolic circulation device 60 is used, the enzyme-carrying microspheres added to the metabolic circulation pipeline L2-4 contain urease, and the urease decomposes urea to produce carbon dioxide and ammonia. A part of the generated carbon dioxide dissolves in the liquid to form a buffer system, and a part forms gas, so that the liquid level of the collection container 600 in the metabolic circulation pipeline L2-4 drops. When the liquid level sensor 602 detects that the liquid level of the collection container 600 reaches a preset low level, the three-way valve or four-way valve or flow channel switching device on the gas branch is activated to discharge excess carbon dioxide. In an embodiment, the urea content in the blood is detected by detecting the pH, urea concentration or ammonia concentration of the metabolic circulation or metabolic circulation effluent, and the urea removal amount, OCM or adsorbent usage are calculated and displayed or prompted. By comparing with the empirical value or historical value, the enzyme activity is reacted or detected, and the operator is prompted to add or replace the enzyme preparation.
[0075] When in use, enzyme-loaded microspheres can be added to the metabolic cycle, and the enzyme-loaded microspheres are circulated in the metabolic circulation pipeline L2-4 driven by the metabolic circulation pump. The treatment method is that the liquid to be treated containing a high concentration of target molecules enters the metabolic circulation pipeline L2-4 through the inlet, and the target molecules are decomposed into corresponding products by the enzyme-loaded microspheres. The metabolic filtration module 605 continuously separates the treated liquid and retains the enzyme-loaded microspheres in the metabolic circulation pipeline L2-4. The treated liquid flows out of the metabolic circulation module through the metabolic filtration module 605.
[0076] In one embodiment, the metabolic circulation device 60 includes: a collection container 600, a metabolic circulation pipeline L2-4, a metabolic circulation pump 606, and a metabolic filtration module 605. In this embodiment, the metabolic circulation device 60 adds the dialysis waste liquid to be treated into the metabolic circulation pipeline L2-4 and drives the circulating liquid flow through the metabolic circulation pump 606, and treats the liquid flow in the circulation to selectively change the structure or concentration of molecules or molecular combinations in the liquid flow. In this process, the treated dialysis waste liquid metabolic treatment liquid in the circulation leaves the circulation, and the residual amount of the preparation of the mixed enzyme-loaded microspheres is retained in the circulation.
[0077] See also Figure 4 , shown is a schematic diagram of the metabolic circulation device of the present application in one embodiment. As shown in the figure, in this embodiment, one end of the metabolic circulation pipeline L2-4 is connected to the second interface a2 of the collecting container 600, and the other end is connected to the third interface a3 of the collecting container 600, thereby forming a circulation loop; in this embodiment, the metabolic circulation pump 606 is arranged on the metabolic circulation pipeline L2-4, and is used to drive the enzyme-loaded microspheres and dialysis waste liquid mixed in the collecting container 600 to circulate in the metabolic circulation pipeline L2-4; the metabolic filtration module 605 is arranged on the metabolic circulation pipeline L2-4, and is used to treat the mixed liquid of the enzyme-loaded microspheres and dialysis waste liquid circulating in the metabolic circulation pipeline L2-4 with toxins, retain the enzyme-loaded microspheres in the metabolic circulation pipeline L2-4, and filter out the dialysis waste liquid metabolic treatment liquid.
[0078] In one embodiment, it also includes a device for controlling the metabolic circulation pump 606 to dynamically balance the total amount of fluid in the metabolic circulation pipeline L2-4 in the metabolic circulation mode, that is, by controlling the flow rate of the dialysate waste introduced into the circulation and the dialysate waste metabolic treatment liquid leaving the circulation in any cycle to maintain the dynamic balance of the total amount of fluid in the cycle, allowing the liquid to be treated containing a high concentration of target molecules to enter the circulation through the inlet, and the target molecules are decomposed into corresponding products by the enzyme-loaded microspheres, and the metabolic filtration module 605 in the metabolic circulation device 60 continuously separates the treated liquid and retains the enzyme-loaded microspheres in the circulation, and the treated liquid flows out of the metabolic circulation module through the metabolic filtration module 605.
[0079] In one embodiment, the metabolic circulation pump disposed on the metabolic circulation pipeline includes: a first metabolic circulation pump and a second metabolic circulation pump, wherein the first metabolic circulation pump is disposed upstream of the metabolic filtration module, and the second metabolic circulation pump is disposed downstream of the metabolic filtration module. Figure 5 , which is a schematic diagram of another embodiment of the metabolic circulation device of the present application. As shown in the figure, the total amount of liquid equilibrium state in the metabolic circulation pipeline L2-4 is changed by the differential speed of the first metabolic circulation pump 606' and the second metabolic circulation pump 606". Figure 5 In the illustrated embodiment, the first metabolic circulation pump 606 ′ and the second metabolic circulation pump 606 ″ are, for example, peristaltic pumps.
[0080] In another embodiment, the metabolic circulation pump disposed on the metabolic circulation pipeline includes a first metabolic circulation pump disposed upstream or downstream of the metabolic filtration module and a second metabolic circulation pump connected in parallel with the first metabolic circulation pump. Fig.20a and Fig.20b , respectively showing the structural schematic diagram of the first metabolic circulation pump and the second metabolic circulation pump of the present application being arranged in parallel upstream or downstream of the metabolic filtration module. As shown in the figure, the first metabolic circulation pump 607' and the second metabolic circulation pump 607" are arranged in parallel on the metabolic circulation pipeline L2-4. The liquid in the collecting container 600 flows into the metabolic circulation pipeline L2-4 from the second interface a2, and the liquid flows into the collecting container 600 from the third interface a3 after passing through the metabolic filtration module and the first metabolic circulation pump 607'. Moreover, the liquid can also flow into the collecting container 600 from the third interface a3 after passing through the metabolic filtration module and the second metabolic circulation pump 607".
[0081] Among them, the first metabolic circulation pump 607' and the second metabolic circulation pump 607" are pneumatic fluid pumps, and correspondingly, valves (not shown in the figure) are arranged on both sides of the first metabolic circulation pump 607' and the second metabolic circulation pump 607". The valve can be a pneumatic fluid valve or a pinch valve, etc. The pneumatic fluid pump uses positive-pressure gas and negative-pressure gas introduced through a pneumatic interface to control the forward or reverse flow of fluid in the fluid channel. In other words, the pneumatic fluid pump uses positive-pressure gas and negative-pressure gas introduced through a pneumatic interface to control the forward or reverse flow of fluid in the metabolic circulation pipeline, wherein the fluid channel is the part of the metabolic circulation pipeline connected to the pneumatic fluid pump and the pneumatic fluid valve. Fig.20a As shown, the inlet of the pneumatic fluid pump is connected to the second interface a2, and the outlet of the pneumatic fluid pump is connected to the metabolic filtration module, then the pneumatic fluid pump can control the fluid to flow forward in the fluid channel, conversely, if the inlet is connected to the metabolic filtration module and the outlet is connected to the second interface a2, then the fluid can be controlled to flow reversely in the fluid channel.
[0082] In one embodiment, the pneumatic fluid pump is used to push fluid into its fluid channel using the positive pressure gas introduced by the pneumatic interface, and to draw fluid into its fluid channel using the negative pressure gas introduced by the first pneumatic interface. Fig.21 , which is a schematic cross-sectional structure diagram of a pneumatic fluid pump in one embodiment of the present application, as shown in the figure, the pneumatic fluid pump includes a fluid chamber 6071, a pneumatic diaphragm 6070, and a gas chamber 6072. In the process of pumping fluid, the valve on the side of the inlet 6080 of the pneumatic fluid pump is opened, and the valve on the side of the outlet 6081 of the pneumatic fluid pump is closed, and the gas chamber 6072 of the pneumatic fluid pump is a negative pressure airflow, and then the pneumatic diaphragm 6070 is forced to deform upward, and the fluid is sucked from the inlet 6080 to the fluid chamber 6071 through the fluid channel 608. In the process of pushing and discharging fluid, the valve on the side of the inlet 6080 of the pneumatic fluid pump is closed, and the valve on the side of the outlet 6081 of the pneumatic fluid pump is opened, and the gas chamber 6072 of the pneumatic fluid pump is a positive pressure airflow, and the pneumatic diaphragm 6070 is forced to deform downward, and then the fluid in the fluid chamber 6071 is discharged from the outlet 6081 via the fluid channel 608.
[0083] In one embodiment, the fluid cavity 6071 is formed on the flow channel plate 610, and further, the fluid channel 608 communicating therewith may also be provided on the flow channel plate 610. Specifically, a plurality of recesses, grooves, openings and other structures reserved on the flow channel plate 610 form the fluid cavity 6071 and the fluid channel 608. In one embodiment, the flow channel plate 610 is injection molded by PMMA, PVC or PC plastic.
[0084] In one embodiment, the fluid cavity 6071 is formed on the inner side of the flow channel plate 610. The inner side of the flow channel plate 610 is the side of the flow channel plate 610 close to the pneumatic diaphragm 6070. In one example, the fluid cavity 6071 is a cavity formed by being recessed on the inner side of the flow channel plate 610 in a direction away from the pneumatic diaphragm 6070. The recessed surface of the fluid cavity may be in an arc shape, a curved shape, or the like.
[0085] In one embodiment, the first surface of the pneumatic diaphragm 6070 covers the fluid cavity 6071. The first surface is the surface facing the flow channel plate 610, and the second surface is the surface away from the flow channel plate 610. The first surface of the pneumatic diaphragm 6070 covers the fluid cavity 6071 and is used to change the volume of the fluid cavity 6071 when subjected to pressure so that the fluid cavity 6071 pushes the fluid into the fluid channel 608 or the fluid cavity 6071 draws the fluid from the fluid channel 608.
[0086] In one embodiment, the pneumatic diaphragm is made of silicone rubber or PVC soft film. The pneumatic diaphragm is deformed by force, and after the force is removed, the pneumatic diaphragm can return to its original state / shape. When the pneumatic diaphragm is deformed downward by force, the cavity pressure in the fluid cavity is positive pressure. For another example, when the pneumatic diaphragm is deformed upward by force, the cavity pressure in the fluid cavity is negative pressure.
[0087] The gas cavity 6072 is covered by the second surface of the pneumatic diaphragm 6070 . In other words, the upper side of the pneumatic diaphragm 6070 is the gas cavity 6072 , and the lower side of the pneumatic diaphragm 6070 is the corresponding fluid cavity 6071 .
[0088] In one embodiment, the gas cavity 6072 is disposed on the airway plate 611, and the airway plate 611 is combined with the flow plate 610 and the pneumatic diaphragm 6070 of the fluid pump 6071. In one embodiment, after the airway plate 611 is combined with the flow plate 610, the two clamp the pneumatic diaphragm 6070 in the middle. In one embodiment, the airway plate is injection molded by PMMA, PVC or PC plastic. A plurality of structures such as depressions, grooves, openings, etc. are reserved on the airway plate.
[0089] In one embodiment, the gas cavity 6072 is formed inside the airway plate 611. A plurality of recesses, grooves, openings and other structures reserved on the airway plate 611 form the gas cavity 6072. The fluid cavity 6071, the gas cavity 6072 and the pneumatic diaphragm 6070 therebetween constitute the pneumatic fluid pump described above.
[0090] The gas cavity 6072 is provided with a gas hole 6074 for connecting to an external gas passage, and the gas hole 6074 provides a positive pressure airflow or a negative pressure airflow into the gas cavity 6072 to drive the pneumatic diaphragm 6070 to change the volume of the fluid cavity 6071. When there is a positive pressure airflow in the gas cavity 6072, the pneumatic diaphragm 6070 is forced to deform downward, and when there is a negative pressure airflow in the gas cavity 6072, the pneumatic diaphragm 6070 is forced to deform upward.
[0091] To this end, the outer side of the airway plate 611 is also provided with a pneumatic interface 609 connected to the air hole 6074. The pneumatic interface 609 is connected to the pneumatic system of the dialysis device so that the pneumatic system provides positive pressure airflow or negative pressure airflow to the gas cavity 6072 to control the forward or reverse flow of the fluid in the fluid channel 608.
[0092] In one embodiment, the flow channel plate and the air channel plate can be combined together by bonding, welding, snapping, or screwing, and the pneumatic diaphragm is clamped between the flow channel plate and the air channel plate. The flow channel plate, the pneumatic diaphragm, and the air channel plate are pre-fixed together to ensure the sealing between the pneumatic diaphragm and the flow channel plate and the air channel plate, so as to ensure the air tightness of the air drive.
[0093] In one embodiment, the pneumatic diaphragm is further provided with a sealing ring 6073 to achieve sealing between the pneumatic diaphragm and the fluid cavity and / or the gas cavity. The sealing ring can be provided on the pneumatic diaphragm by gluing or the like, or can be integrally formed with the pneumatic diaphragm.
[0094] Setting the first metabolic circulation pump 607' and the second metabolic circulation pump 607" as pneumatic fluid pumps can not only realize the functions of traditional peristaltic pumps, but also reduce the number of electrical components in the dialysate regeneration circulation system and the dialysis device including the dialysate regeneration circulation system, reduce the complexity of the device and improve the integration of the device.
[0095] Since the pneumatic fluid pump alternately sucks and discharges fluid, the pneumatic fluid pump cannot suck fluid when discharging fluid, and the pneumatic fluid pump cannot discharge fluid when sucking fluid. In order to ensure that the metabolic circulation pipeline always has fluid flowing continuously, and to avoid blockage of enzymes or enzyme preparations or enzyme-loaded microspheres in the metabolic cycle, the first metabolic circulation pump 607' and the second metabolic circulation pump 607" work alternately to drive the flow of liquid in the metabolic cycle. For example, when the first metabolic circulation pump 607' is sucking liquid, the second metabolic circulation pump 607" is discharging fluid, and correspondingly, when the first metabolic circulation pump 607' is discharging liquid, the second metabolic circulation pump 607" is sucking fluid. In this way, it can be ensured that the metabolic circulation pipeline always has fluid flowing continuously.
[0096] In one embodiment, the valves arranged on both sides of the first metabolic circulation pump 607' and the second metabolic circulation pump 607" are pneumatic fluid valves. The structure of the pneumatic fluid valve is similar to that of the pneumatic fluid pump. The pneumatic fluid valve also includes a fluid cavity, a pneumatic diaphragm, and a gas cavity. When a positive pressure airflow is introduced into the gas cavity, the pneumatic diaphragm is forced to deform downward, and the pneumatic fluid valve is closed; when a negative pressure airflow is introduced into the gas cavity, the pneumatic diaphragm is forced to deform upward, and the pneumatic fluid valve is opened. In one embodiment, the fluid cavity and the gas cavity of the pneumatic fluid valve can also be correspondingly integrated in the flow channel plate and the air channel plate, and the pneumatic diaphragm of the pneumatic fluid valve and the pneumatic diaphragm of the pneumatic fluid pump can be integrated or independent.
[0097] In order to reduce the manufacturing cost of the equipment, the pneumatic fluid pump and the pneumatic fluid valve in the metabolic circulation device usually share a pneumatic system. When the two share a pneumatic system, when the pneumatic system supplies positive pressure airflow of equal pressure to the pneumatic fluid pump and the pneumatic fluid valve, the fluid in the fluid cavity of the pneumatic fluid pump will be quickly pushed into the fluid channel, causing turbulence, and further destroying the microstructure of the enzyme or enzyme preparation or enzyme-loaded microspheres.
[0098] To this end, the pneumatic interface of the pneumatic fluid pump is provided with a gas damping element, which is used to limit the instantaneous flow rate of the airflow entering the gas cavity of the pneumatic fluid pump. Specifically, when the positive pressure airflow passes through the gas damping element, the instantaneous flow rate of the airflow is reduced, thereby promoting the fluid in the fluid cavity of the pneumatic fluid pump to be smoothly pushed into the fluid channel, avoiding turbulence and avoiding damage to the microstructure of the enzyme or enzyme preparation or enzyme-loaded microspheres.
[0099] In one example, the gas damping element is disposed at the inlet end of the pneumatic interface. In other examples, the gas damping element can also be disposed at any position on the gas source connecting pipeline connecting the positive pressure gas source of the pneumatic system and the pneumatic fluid pump.
[0100] In some embodiments, the gas damping element is a small-diameter pipeline. For example, the diameter of the gas damping element is 1 / 2-1 / 10 of the diameter of the pneumatic interface. For another example, the diameter of the gas damping element is 1 / 2-1 / 10 of the diameter of the gas source connecting pipeline, and the instantaneous flow rate of the airflow entering the gas cavity of the pneumatic fluid pump is limited through the small-diameter pipeline. In another embodiment, the gas damping element is exemplified by an airflow regulating valve, and the airflow regulating valve is a high-frequency valve, which can limit the instantaneous flow rate of the airflow entering the gas cavity of the pneumatic fluid pump through high-frequency shutoff and opening.
[0101] See also Figure 6 , which is a schematic diagram of the metabolic circulation device of the present application in another embodiment. As shown in the figure, in this embodiment, the first interface a1 of the collection container 600 is connected to the output end of the waste liquid passage L2-1, and the collection container 600 includes a liquid storage space 6001 located in the lower part of the cavity and a gas collection space 6000 located in the upper part of the cavity. That is, the collection container 600 is divided into two spaces according to function, the upper gas collection space 6000 is used for gas collection, and the lower liquid storage space 6001 is used to collect liquid passing through the collection container 600, that is, there is a gas-liquid separation layer in the collection container 600, and the liquid in the collection container 600 flows from the second interface a2 into the metabolic circulation pipeline L2-4, and flows into the collection container 600 from the third interface a3. Of course, in the case of the reverse of the metabolic circulation pump 606, the liquid in the collection container 600 flows from the third interface a3 into the metabolic circulation pipeline L2-4, and flows into the collection container 600 from the second interface a2. In this embodiment, a fourth interface a4 is provided on the top of the collecting container 600 for connecting with the gas branch L2 - 5 .
[0102] In this embodiment, the liquid storage space 6001 includes a first extension part 60010 and a second extension part 60011 extending downwards respectively; wherein the second interface a2 is provided at the bottom end of the first extension part 60010; the third interface a3 is provided at the bottom end of the second extension part 60011, and the isolation part 60012 is higher than the second interface a2 and the third interface a3. In this embodiment, in order to ensure that the inlet and outlet of the liquid storage space 6001 are at the lowest position, the second interface a2 and the third interface a3 are respectively provided at the bottom ends of the first extension part 60010 and the second extension part 60011 extending downwards, so that no matter whether the fluid flows from the second interface a2 to the third interface a3, or from the third interface a3 to the second interface a2, in the collecting container 600, the fluid flows from the bottom to the top. In this embodiment, the first extension part 60010 and the second extension part 60011 of the liquid storage space 6001 both extend downwards, and it should be understood that the “extending downwards” refers to extending vertically downwards, and may also include extending obliquely downwards.
[0103] In another embodiment, one of the first extension portion and the second extension portion of the liquid storage space extends horizontally, and the other extension portion extends downward, so that the first extension portion and the second extension portion have an incident angle. In specific practical implementations, the angle of the incident angle can be designed accordingly based on actual parameters such as the flow rate, bubble content, or fluid flow rate of the fluid.
[0104] In an embodiment, the length of the first extension portion with the second interface or the second extension portion with the third interface is related to the flow rate, bubble content, or fluid flow rate of the fluid in the liquid storage space; or the length of the isolation portion located between the first extension portion and the second extension portion is related to the flow rate, bubble content, or fluid flow rate of the fluid in the liquid storage space; or the shortest flow distance of the fluid flowing from one interface of the second interface or the third interface to the other interface is related to the flow rate, bubble content, or fluid flow rate of the fluid.
[0105] In an embodiment, a fluid such as a liquid flows from a first extension portion having a second interface through an internal space of a collecting container to a second extension portion having a third interface. The shortest flow distance of the liquid is controlled by designing the internal structure of the collecting container and the relative positions of the second interface and the third interface, so that bubbles in the liquid can float up and escape and achieve the purpose of gas-liquid interface separation. The shortest flow distance of the liquid is related to the bubble content, flow rate, or flow rate of the liquid. For example, the higher the bubble content in the liquid, or the faster the flow rate, or the larger the flow rate, in practice, the longer the shortest flow distance of the liquid needs to be designed. Corresponding to different embodiments, for example, in one example, when the bubble content in the liquid is higher, or the flow rate is faster, the length of the first extension part or the second extension part is longer; in another example, when the bubble content in the liquid is higher, or the flow rate is faster, or the flow rate is larger, the length of the isolation part located between the first extension part and the second extension part is longer; in yet another example, when the bubble content in the liquid is higher, or the flow rate is faster, or the flow rate is larger, the shortest flow distance of the fluid flowing from one of the second interface or the third interface to the other interface needs to be longer.
[0106] In this embodiment, in order to adjust the flow resistance of the fluid passing through the gas collecting chamber or to generate turbulence, or to adjust the flow rate of the fluid passing through the gas collecting chamber, so as to facilitate the gas / bubbles carried in the fluid to be enriched above the liquid level of the liquid storage space, the length of the first extension part and / or the second extension part can be appropriately increased or shortened in actual applications; of course, the above purpose can also be achieved by changing the length of the isolation part between the first extension part and the second extension part. In some embodiments, the isolation part is a step structure relative to the first extension part and / or the second extension part; the isolation part is an arched structure relative to the first extension part and / or the second extension part; or the isolation part is a baffle structure extending upward from the bottom of the gas collecting chamber; for example, the gas collecting chamber is roughly A-shaped, inverted V-shaped, inverted U-shaped, n-shaped, or "mountain"-shaped, etc., with a bottom extension shape or structure.
[0107] It should be noted that in order to better achieve gas-liquid separation, in one embodiment of the present application, the path cross-section of the fluid flowing from one of the second interface or the third interface to the other interface is larger than the cross-section of the second interface or the third interface, that is, by designing a redundant space structure for the internal space of the gas collecting chamber or the flow channel of the fluid, so that the cross-section of the liquid flow path is much larger than the cross-sectional area of the interface (the second interface or the third interface), so as to reduce the liquid flow rate and increase the gas escape time. For example, when the liquid flows horizontally, the cross-sectional area in the horizontal direction gradually increases, the flow rate gradually decreases, and the flow rate is consistent, so that the gas can easily escape.
[0108] In one embodiment, if Figure 6 As shown, the first interface a1 of the collection container 600 is connected to the output end of the waste liquid passage L2-1, and is used to mix the added enzyme-loaded microspheres and the dialysis waste liquid to fully contact. In this embodiment, the collection container 600 is provided with a sample addition port (not shown) for adding an enzyme preparation (enzyme-loaded microspheres containing urease). Specifically, the sample addition port contains a valve or a clamp for switching and closing the sample addition port. The shape of the sample addition port can be designed to be easy for syringe connection and has a certain air tightness. The collection container 600 is, for example, a transparent liquid bag, for example, a liquid bag made of medical plastic.
[0109] In certain embodiments, the sample addition port in the metabolic circulation device is also equipped with a sample addition device for adding, supplementing or replacing reaction substrates, catalytic units, drugs, and other auxiliary factors or activators to the metabolic circulation pipeline L2-4. In this example, the sample addition device can be used as a processing unit, and the sample addition device can be manually controlled or controlled by a computing device to add, supplement or replace catalytic units and reaction substrates, activators, etc. to the metabolic circulation pipeline L2-4, thereby achieving the processing of the fluid. In actual scenarios, the sample addition device can also be used to control the concentration of the catalytic unit in the cycle. For example, when the concentration of the target substance in the fluid to be treated is different, the corresponding amount of the catalytic unit added to the pipeline can be controlled to achieve a preset reaction effect.
[0110] The sample adding device can be configured as a component integrated with the pipeline, or as a component having two opposite access ports to connect the pipeline and ensure that the fluid forms a circulation. Through the sample adding device, the catalytic unit or reaction substrate can be immediately added to the metabolic circulation pipeline L2-4; wherein, the reaction substrate can be any component in the fluid to be treated or a substance that can react with any component in the fluid to be treated, and the reaction includes but is not limited to biological reaction, chemical reaction, and physical reaction. The auxiliary factor or activator can be used to assist the catalytic unit to react with the target substance, for example, when the catalytic unit is a metal enzyme that requires metal ions as auxiliary factors.
[0111] In one example, the sample adding port of the sample adding device may also be configured with a corresponding stopper or sealing cover, which is used to be opened during sample adding and closed after sample adding is completed, so as to ensure that the interior of the pipeline remains relatively airtight.
[0112] In another example, the sample adding device may be configured with a permeable component such as a rubber stopper, and a sample adding port may be formed by injection or puncture when adding samples. For example, the catalytic unit or reaction substrate to be added to the pipeline is stored in a syringe, and the rubber stopper is pierced by the syringe to add the catalytic unit or reaction substrate to the sample adding device.
[0113] In an embodiment, the collecting container has a collecting chamber for mixing the circulating catalytic unit, the fluid surplus and the liquid to be treated so as to make the catalytic unit contact with the target substance.
[0114] In one embodiment, the collecting container can be used to expand the circulation volume. In each example where the fluid is a liquid, the collecting container can help the circulating liquid and the circulating catalytic unit to be better mixed, thereby achieving full contact between the target substance and the catalytic unit.
[0115] In some embodiments, the collection container is also used to set a sample addition port, an air discharge port, or a liquid discharge port. In this example, the collection container can also serve as an integration platform for various liquid inlets and outlets or air inlets and outlets and a place for the intersection and mixing of various liquids.
[0116] In one embodiment, by determining the position of the collecting container in the pipeline, the fluid in the collecting container tends to flow in the circulation direction due to gravity when placed naturally. This design can avoid or reduce the generation of bubbles in the pipeline. In this example, the collecting device can also be provided with an exhaust port connected to the gas branch L2-5 to adjust the internal air pressure of the circulation.
[0117] like Figures 2 to 8 As shown, in one embodiment, a liquid level sensor 602 is provided on the collecting container 600 for detecting the liquid level in the collecting container 600 . The liquid level sensor 602 can transmit a signal to decide whether to control the liquid level in the collecting container 600 .
[0118] In one embodiment, a color sensor 601 is provided on the collection container 600 for detecting the color of the liquid in the collection container 600 to detect information such as the content or concentration of enzyme-loaded microspheres, or as a detection signal to indicate whether the operator has added enzyme-loaded microspheres, so as to ensure the correct operating procedures and programmed operation of the dialysis equipment.
[0119] In one embodiment, the metabolic circulation device 60 also includes a gas branch L2-5, which is used to control the amount of liquid in the collecting container 600 by exhausting or intake. In this embodiment, an air pump 6030 is provided on the gas branch L2-5, and the air pump 6030 is connected to a gas inlet and outlet. An exhaust valve 6031 or a flow channel switching device is provided on the exhaust branch L2-5, which is used to connect or close the circulating gas on the exhaust branch. The exhaust valve 6031 is, for example, a three-way valve or a four-way valve. A hydrophobic filter 6230' is provided on the gas branch L2-5. The exhaust branch L2-5 is provided with a pressure sensor 6231'' for detecting the pressure in the cavity of the collecting container 600. The pressure sensor 6231'' can reflect the metabolic circulation or / and the fluid pressure conditions downstream.
[0120] See also Figure 7, which is a schematic diagram of another embodiment of the metabolic circulation device of the present application. As shown in the figure, two air pumps (6030', 6030") are arranged on the gas branch L2-5, namely a first air pump 6030' for degassing and a second air pump 6030" for adding gas. An exhaust valve 6031 or a flow channel switching device is arranged between the first air pump 6030' and the second air pump 6030", and the liquid level and liquid amount in the collecting container 600 are controlled by selectively controlling the first air pump 6030' or the second air pump 6030".
[0121] In the embodiment, the pressure sensor 6231", the air pump (6030', 6030"), and the hydrophobic filter 6230' are connected to the gas branch L2-5 through a three-way or four-way valve or a flow channel switching device. The gas branch L2-5 is located on the collection container 600. When in use, the pressure sensor 6231" is connected. When fast exhaust is required, the exhaust port is connected. When slow exhaust is required, the degassing pump (such as Figure 7 When air is required, the first air pump 6030' is connected to the air pump (such as Figure 7 The second air pump 6030" is shown).
[0122] In an embodiment, the liquid level in the collection container 600 can be controlled by transmitting a signal through the liquid level sensor 602, or the liquid level or gas content in the collection container 600 can be determined through the liquid level sensor 602 or the pressure sensor 6231", and then the air pump (6030', 6030") or the exhaust valve 6031 on the gas branch L2-5 can be used to automatically control the closing of the exhaust port to discharge the gas generated by the reaction in the metabolic cycle, or to control the total amount of liquid in the metabolic cycle, or to control the total amount of liquid in the dialysate regeneration cycle. In some embodiments, the total amount of the dialysate regeneration cycle is in addition to the above Figure 1 The content shown, for example, also includes the outer cavity of the dialyzer and other water channels similar to those of traditional dialysis machines, such as being equal to the total amount of dialysis waste fluid and regeneration fluid.
[0123] See also Figure 8 , which is a schematic diagram of the metabolic circulation device of the present application in another embodiment. As shown in the figure, a weighing device 604 is provided at the bottom of the collection container 600, which is used to detect the weight of the liquid in the collection container 600 to determine the capacity of the liquid in the collection container 600, and then control the liquid level and liquid volume in the collection container 600 through an air pump (6030', 6030").
[0124] In the embodiment, when used to detect the concentration of target molecules in the liquid to be treated in the collection container, the concentration of the target molecules or the cumulative treatment volume is detected by measuring the pH, substrate concentration, or product concentration of the active effluent in the metabolic cycle, so as to reflect the use of the downstream adsorption device. Furthermore, the concentration of the substance detected by the above sensor can be used to display or prompt the concentration of the initial, treated, or remaining target molecules and product molecules OCM (on-line clearance monitoring, online urea clearance monitoring, abbreviated as OCM), or by comparing with the empirical value or historical value or agreed value to reflect or detect the activity of the enzyme. If the measured value is much lower than the historical value or the preset value, the operator is prompted to add or replace the enzyme preparation.
[0125] The present application can realize the design of HDF treatment mode, i.e., hemodiafiltration with dynamic control of the total amount of (circulating dialysate) by setting gas branch L2-5 in the metabolic circulation device. The total amount of liquid in the dialysate circulation is controlled by dynamically and periodically regulating the volume or liquid level of any container in the dialysate circulation, thereby realizing periodic filtration and filtration, and increasing the molecular convection exchange of the dialyzer.
[0126] Assuming that the volume of the collection container is about 20-30 mL, the exhaust valve, such as a four-way valve, can be connected to an air pump or a pressure sensor for degassing or aeration. Under standard conditions, the liquid level in the collection container is at a low level, and the air is about 25 mL. Due to the continuous injection of liquid into the dialysis waste liquid passage L2-1, the air chamber in the collection container is at a positive pressure.
[0127] In an embodiment, one HDF process can be divided into a plurality of identical cycles, or gas pump (6030', 6030") gas filling or degassing cycles, such as the above Figure 7 As exemplified.
[0128] During the degassing cycle (assuming 30 seconds), the liquid level in the collection container rises slowly during the degassing process, and the amount of water in the blood filtered to the dialysate side increases. If the degassing speed of the air pump is 46 ml / min, the filtered water is 23 mL.
[0129] During the gas filling cycle (assuming 30 seconds), the gas pressurized liquid level drops, and more dialysate is filtered into the blood at the same rate of 46 ml / min. That is, the increased filtration rate in one cycle (1 minute) is 23 mL, so the filtration volume in the entire treatment cycle of 240 minutes is 5.52 L.
[0130] In another embodiment of increasing the filtration volume, if the gas filling cycle is shorter than the degassing cycle, the gas filling speed is faster, for example, the gas filling is completed in 5 seconds, and the flow rate is 276ml / min; in this case, the time of one cycle is 35s, and the treatment time of 240min can work 411.4 cycles, and the total filtration volume is 9.45L.
[0131] Although exhaust can be performed by setting up a gas branch L2-5 in the metabolic circulation device, various devices such as an air pump and a pressure sensor need to be set up, which increases the complexity of the metabolic circulation device and further increases the manufacturing cost.
[0132] To this end, in another embodiment, see Fig.22a and Figure 22b , which is a schematic diagram of the structure of the metabolic circulation device of the present application in one embodiment, such as Fig.22a As shown, an exhaust port 6000 is provided at the top of the collecting container 600, and a floating valve ball 6001 is suspended in the collecting container 600 corresponding to the exhaust port 6000. The floating valve ball 6001 is used to seal the exhaust port as the liquid level in the collecting container 600 rises, and to open the exhaust port as the liquid level in the collecting container 600 drops. Specifically, the gas in the collecting container 600 will rise and gather at the top of the collecting container 600. As the gas gradually increases, the liquid level in the collecting container 600 gradually drops. When the liquid level drops, the floating valve ball 6001 drops with the liquid level to open the exhaust port 6000, and the gas is discharged from the exhaust port 6000. When the liquid level rises, Figure 22b As shown, the floating valve ball 6001 rises with the liquid level, and when the floating valve ball 6001 rises to the top of the collection container 600, it seals the exhaust port 6000 to prevent the liquid from being discharged from the exhaust port 6000. In this way, the gas in the collection container 600 can be removed and the complexity of the metabolic cycle device can be reduced, such as reducing the setting of electrical components or elements.
[0133] In the embodiment, the enzyme preparation is reusable, and through the above-mentioned "prefabricated liquid bypass" method, an empty prefabricated liquid bag is connected to the metabolic circulation, the liquid and enzyme-carrying microspheres in the metabolic circulation are flushed into the bag, and the enzyme preparation (more diluted enzyme preparation) is stored at low temperature. At the next treatment, the bag is connected to the metabolic circulation pipeline, inverted, with the outlet at the bottom, and the enzyme preparation is supplemented to the metabolic circulation, or a part of the enzyme preparation is supplemented according to the empirical value, and then it is continued for dialysis treatment.
[0134] In one embodiment, the enzyme preparation separation is achieved through a metabolic filtration module, which includes a separation component to separate the metabolic filtration module into a first side and a second side, wherein the two opposite ends of the first side of the metabolic filtration module are respectively connected to the inlet and outlet of the metabolic circulation pipeline L2-4, and the second side of the metabolic filtration module is connected to the input end of the adsorption device. In some embodiments, the metabolic filtration module can also be called a separation module.
[0135] In this embodiment, the metabolic circulation pump drives the enzyme-loaded microspheres and dialysis waste liquid mixed in the collection container to circulate in the metabolic circulation pipeline L2-4 at a preset flow rate; during the period, the preset flow rate is related to at least one of the target substance, fluid composition, fluid temperature, separation component structure, separation component material, metabolic filtration module cavity structure, pipeline diameter, and fluid exchange efficiency. The metabolic circulation pump can be upstream or downstream of the metabolic filtration module, and the direction of the metabolic circulation pump driving the liquid flow can be any single direction, or it can be the opposite direction, or the flow direction can be periodically adjusted, such as 1min forward drive, 1min reverse drive, or 10min forward drive, 1min reverse drive, etc., to reduce the deposition of enzyme-loaded microspheres in the metabolic filtration module.
[0136] In an embodiment, the inlet and outlet of the pipeline in the metabolic circulation module are connected to the two ports corresponding to the metabolic filtration module, so that the pipeline and the metabolic filtration module can jointly form a circulation passage, and the metabolic circulation pump controls the flow rate of the fluid in the pipeline, for example, by controlling the fluid rate introduced into the metabolic circulation module to be equal to the fluid rate leaving the circulation based on the metabolic filtration module, the total amount of fluid in the pipeline can be dynamically balanced.
[0137] The fluid in the pipeline contacted by the metabolic filtration module can thus achieve selective permeation of components in the fluid based on the metabolic filtration module, and make the components that can penetrate the metabolic filtration module pass through the separation component from one side to the other side, so as to achieve the separation effect. That is, the proxy filtration module can be regarded as a processing unit with a selective treatment function for the treated fluid (such as the mixed enzyme-loaded microspheres and dialysis waste liquid in the present application). In some examples, the fluid may also include a catalytic unit, and correspondingly, the metabolic filtration module can be set to a structure or material that is not permeable to the catalytic unit, so as to achieve the enzyme-loaded microsphere retention effect.
[0138] Here, the first side and the second side are used to distinguish the position of the fluid component that can pass through the metabolic filtration module and the trapped fluid (liquid containing enzyme-loaded microspheres), and the positional relationship between the first side and the second side is determined by the cavity structure of the metabolic filtration module and the structure of the separation component. For example, when the separation component is a planar structure and is laterally arranged in the proxy filtration module, the first side and the second side are respectively the upper side and the lower side; or when the separation component is a planar structure and is vertically arranged in the proxy filtration module, the first side and the second side are respectively the left side and the right side.
[0139] It should be understood that in the embodiments provided in the present application, the cavity in the metabolic filtration module that is connected to the pipeline is the first side, and the other cavities in the metabolic filtration module are the second side; in one example, when the metabolic filtration module includes multiple cavities, for example, the metabolic filtration module is divided into multiple cavities by multiple separation components in the form of plate membranes, the cavity connected to the pipeline among the multiple cavities is the first side, and the remaining cavities are the second side.
[0140] In certain embodiments, the separation component is a structure or material that has selective permeability to some components in the fluid, such as a filter, a filter membrane, or a porous metal material.
[0141] In certain embodiments, the separation component is a separation membrane, and the selective permeability of the separation membrane can be used to selectively remove molecules or combinations of molecules from the treated fluid (e.g., the mixed enzyme-loaded microspheres and dialysis waste in the present application), for example, so that the enzyme-loaded microspheres are retained in the circulation.
[0142] In some embodiments, the separation component is a porous membrane, wherein the porous membrane includes a microfiltration membrane, an ultrafiltration membrane, or a nanofiltration membrane. Here, the average pore size or molecular weight cutoff (MWCO) of the porous membrane or reverse osmosis membrane is related to the target substance. In an actual scenario, based on the fluid components and the determined target substance, a porous membrane suitable for intercepting the target substance is selected. For example, when the target substance to be intercepted in the fluid has a particle size of 10 nm (i.e., 0.01 μm), the corresponding separation membrane can use a nanofiltration membrane or a reverse osmosis membrane to achieve the interception of the target substance. Here, the specific type of the separation membrane can be determined based on the differences in the physicochemical properties between the components of the fluid and the target substance, and includes, for example: reverse osmosis membrane (average pore size 0.0001-0.001 μm), nanofiltration membrane (average pore size 0.001-0.01 μm) ultrafiltration membrane (average pore size 0.01-0.1 μm) microfiltration membrane (average pore size 0.1-10 μm), electrodialysis membrane, permeation vaporization membrane, liquid membrane, gas separation membrane, electrode membrane, etc.
[0143] In certain embodiments, the separation membrane achieves the interception, filtration or exchange of the components in the catalytic unit and the fluid through steric effect, Donan effect or electrostatic effect, adsorption, diffusion, charge repulsion effect, pore effect, or dissolution.
[0144] In some embodiments, especially in the dialysis medical application of the present application, the separation membrane is a high-purity polymer with inactive chemical properties and good blood compatibility and tissue compatibility.
[0145] When the target substance is a substance that needs to be retained by the metabolic filtration module (such as the enzyme-loaded microspheres described in the present application), the average pore size or molecular weight cutoff of the porous membrane or reverse osmosis membrane is related to the target substance. In actual scenarios, based on the fluid components and the determined target substance, a membrane that is suitable for retaining the target substance or filtering the target substance is selected. For example, when the target substance to be retained in the fluid has a particle size of 10 nm (i.e., 0.01 μm), the corresponding separation membrane can use a nanofiltration membrane or a reverse osmosis membrane to achieve retention of the target substance.
[0146] In some practical application scenarios, the separation component of the metabolic filtration module can be used to determine the corresponding separation membrane pore size and type based on its ability to retain more than 90% of the target substance. Alternatively, based on higher separation effect requirements, the separation component can be set to have a retention rate of more than 95% or even more than 99% to determine the corresponding separation membrane pore size and type.
[0147] In some embodiments, the average pore size or molecular weight cutoff of the separation component is related to at least one of the catalytic unit, the target substance, and the target product.
[0148] In one embodiment, a catalytic unit may also be provided in the metabolic circulation device. To achieve the retention of the catalytic unit in the pipeline, the average pore size or molecular weight cutoff of the separation component may be correspondingly set to be smaller than the particle size or molecular weight of the catalytic unit. It should be noted that in the circulation module, the separation component may also achieve selective permeation of some components in the treated fluid, while the retention component may be set to only retain the catalytic unit; at the same time, it should be understood that the target substance retained by the separation component and the target substance that can react under the action of the catalytic unit may refer to the same substance or different substances.
[0149] In an embodiment, the separation component can also be configured as a separation membrane of different geometric shapes to adapt to different fluids or achieve different filtering effects. In certain embodiments, the separation component includes one or more of a flat membrane, a tubular membrane, a rolled membrane, a spiral membrane, and a hollow fiber membrane. In terms of microstructure, the separation membrane can include, for example, a symmetric membrane, an asymmetric membrane, a composite membrane, a multilayer composite membrane, and the like.
[0150] It should be noted that, based on the different geometric shapes of separation membranes set in the separation component, the positional relationship between the first side and the second side of the corresponding proxy filtration module may be different; for example, when the separation component is a planar membrane, the first side and the second side are opposite sides of a planar structure barrier; for another example, when the separation component is a hollow fiber membrane, the first side is the inner side of each fiber membrane tube wall, and the second side is the outer side of each fiber membrane tube wall.
[0151] The flow angle of the fluid relative to the separation membrane can be set to different angles, such as 0° to 90°. Here, when the flow angle of the fluid relative to the separation membrane is 0°, the fluid flows parallel to the surface of the separation membrane, such as common tangential flow filtration; when the flow angle of the fluid relative to the separation membrane is 90°, the fluid flows in a direction perpendicular to the membrane surface, such as conventional dead-end filtration (also called vertical filtration).
[0152] In certain embodiments, the flow channel in the proxy filtration module may be configured in a folded reciprocating form, a spiral form, or a flow channel size gradient form, for example, by folding a planar membrane to increase the contact surface area between the fluid and the planar membrane, and correspondingly configuring the flow channel in a folded reciprocating form to match the structural form of the separation membrane, thereby ensuring that the separation membrane separates the proxy filtration module into a first side and a second side.
[0153] In some embodiments, the metabolic circulation pump controls the fluid to flow in the pipeline at a preset flow rate so that the catalytic unit flows from one end of the pipeline through the proxy filtration module to the other end of the pipeline; for example, when the metabolic filtration module is a TFFM, the flow direction of the fluid is parallel to the separation membrane in the TFFM. Here, when the fluid passes through the separation membrane in the TFFM, a transmembrane pressure difference perpendicular to the membrane surface is generated on both sides of the membrane to drive the small molecular weight components in the fluid to pass through the separation membrane and reach the other side. The small molecular weight components that pass through the separation membrane can leave the circulation, and the trapped catalytic unit or other macromolecular components that are preset to be trapped are washed away from the membrane surface under the momentum of the fluid and continue to circulate in the pipeline. The pressure difference on both sides of the membrane in the TFFM is related to the preset flow rate. At the same time, the trapped substances need a certain momentum to overcome the inhibition between molecules or between molecules and membranes to continue to circulate. The driving device controls the flow rate in the pipeline, which can be used to control the pressure difference on both sides of the separation membrane to achieve the interception and separation effect, and can be used to prevent inhibition to ensure the sustainability of the circulation in the pipeline.
[0154] The fluid flow rate at the proxy filter module is related to different parameters, for example, based on different fluid properties such as fluid density and viscosity, the boundary layer shape of the fluid at the proxy filter module such as the surface shape of the separation membrane (i.e., membrane structure) and the cavity structure of the proxy filter module, the interaction force between the fluid and the separation membrane such as the membrane surface roughness determined by the membrane material and the attraction between the fluid and the separation membrane, the flow rate relationship between the proxy filter module and the pipeline inlet determined by the cavity structure of the proxy filter module and the pipeline diameter, the fluid flow rate at the proxy filter module may change; Here, the preset flow rate is used to determine the fluid flow rate at the pipeline inlet flowing to the proxy filter module, and the preset threshold value can be used as the initial flow rate at the proxy filter module. Based on the initial flow rate and the influencing parameter of the fluid flow rate at the aforementioned proxy filter module, the fluid flow rate in the proxy filter module can be determined based on controlling the preset flow rate to generate a pressure difference for achieving separation and prevent the trapped macromolecules such as the catalytic unit from being blocked on the membrane surface, thereby, the macromolecules can flow from the pipeline inlet through the proxy filter module to the pipeline outlet.
[0155] In certain embodiments, the preset flow rate is related to the exchange efficiency of the target product. For example, in TFFM, the target product needs to be driven by the pressure difference on both sides of the separation membrane to flow to the other side after reaching a certain flow rate, thereby leaving the cycle; the pressure difference is related to the flow rate. When the flow rate is too low, the exchange efficiency of the target product flowing across the membrane may decrease. Therefore, the preset flow rate can also be determined by the exchange efficiency.
[0156] In one embodiment, the metabolic filtration module includes N sub-filtration modules, and the N sub-filtration modules are connected in series or / and in parallel, wherein N is a positive integer greater than 2. In certain embodiments, the N sub-filtration modules are connected in series according to a connection order, and the average pore size or molecular retention corresponding to the separation components of the N sub-filtration modules decreases in sequence.
[0157] In some embodiments, the metabolic filtration process is implemented by N cycles, and N groups of metabolic cycle modules corresponding to the N cycles respectively process different molecules or molecular combinations in the fluid, so that different components in the fluid are distributed and processed in the N cycles; wherein N is a positive integer greater than 2.
[0158] Here, the processing types performed by the N groups of processing units may be different. For example, according to the cycle connection order, the treated fluid is filtered in the first cycle, heated in the second cycle, and catalytically treated in the third cycle.
[0159] Alternatively, the processing categories performed by the N groups of processing units may be the same, but correspond to different target substances respectively; for example, the N groups of processing units corresponding to the N cycles are all used to perform catalytic treatment on the fluid to be treated, so that different target substances are distributed in the N cycles and contact different catalytic units respectively.
[0160] In certain embodiments, the fluid is introduced into N circulation modules for treatment, and the N circulation modules are connected in series and / or in parallel, wherein N is a positive integer greater than 2 (N≥2).
[0161] In one embodiment, the metabolic circulation device has a discharge port (not shown) for discharging the enzyme-loaded microspheres in the metabolic circulation device. The discharge port is connected to a storage device for storing the discharged enzyme-loaded microspheres. The enzyme-loaded microspheres are discharged from the discharge port by centrifugation or membrane filtration, such as slowly filtering by gravity or centrifuging to discharge the enzyme-loaded microspheres from the metabolic circulation device into a storage device such as a liquid bag made of medical plastic.
[0162] In one embodiment, the metabolic circulation device is a metabolic circulation device that can be reused after sterilization. In this embodiment, the upstream and downstream pipelines of the reusable circulating metabolic module contain non-liquid contact instant sterilization devices, such as non-contact sterilization devices such as ultraviolet rays, gamma rays, or bacterial filtration membranes, usually 0.22um or 0.45um membranes.
[0163] In some embodiments, the metabolic cycle reflux is, for example, a loop or a loop system or a loop in a circulation treatment system constituted by the "metabolic cycle module" described in patent document WO2022036739A1 or / and patent document WO2022036738A1; in the present application, the full text of patent documents WO2022036739A1 and WO2022036738A1 is cited herein.
[0164] See also Figures 2 to 8 Combined with Figure 1 The input end of the adsorption device 61 is connected to the output end of the metabolic circulation device 60, and is used to perform a secondary toxin treatment on the waste liquid after the first toxin treatment by the metabolic circulation device 60 to generate a regeneration liquid; the adsorption device 61 uses an adsorption material to catalytically decompose and adsorb the dialysis waste liquid after exchange with blood to produce a dialysis regeneration liquid that enters the regeneration liquid pipeline L2-7.
[0165] In this embodiment, the adsorption device may not contain a urease layer, and the adsorption device is an adsorption column comprising zinc phosphate, hydrated zirconium oxide, and activated carbon. Among them, the activated carbon material is used to adsorb organic substances from the dialysis waste liquid, and the zirconium phosphate layer material is used to adsorb various cationic substances, including potassium, calcium, magnesium and ammonium ions, wherein the ammonium ions are the products of urease decomposition of urea, so the zirconium phosphate layer must be downstream of the urease layer or the metabolic cycle, while adsorbing cations, zirconium phosphate will release hydrogen ions or sodium ions, and zirconium phosphate is a cation exchange material, and the hydrated zirconium oxide layer material is used to adsorb various anionic substances, such as phosphate, acetate, etc., and the hydrated zirconium oxide is an anion exchange material.
[0166] In one embodiment, the adsorption device is a single column containing multiple adsorption materials. For example, the adsorption device includes multiple layers of material, which is designed to remove pollutants and uremic solutes while retaining appropriate dialysate components. The waste dialysate flows through the filter cartridge from bottom to top. The layer in contact with the dialysate contains activated carbon. These layers absorb heavy metals, chloramines and other pollutants that may be found in tap water. In addition, activated carbon absorbs many organic and middle molecular uremic solutes found in the waste dialysate, including creatinine and uric acid. The multilayer material includes a zirconium phosphate layer and is a cation exchange layer. Its main function is to adsorb ammonium ions produced by urea hydrolysis. In addition, this cation exchange material absorbs other positively charged substances, such as magnesium, calcium and potassium, and heavy metal cations that may be found in tap water, such as copper and iron. For the adsorbed cations, in order to achieve exchange, the zirconium phosphate releases or and sodium. The multilayer material also includes an anion exchange layer containing hydrated zirconium oxide. The material adsorbs phosphate, fluoride and other anions, such as oxygen anions of heavy metals, and releases water or hydroxide anions in exchange. For example, the filler of the traditional adsorption column in patent document US10603421B2 has a certain hierarchy and upstream and downstream relationship. In particular, the zirconium phosphate layer needs to be downstream of the urease layer to adsorb the amine ions produced by urease decomposition of urea, that is, the dialysis waste liquid to be treated first passes through the urease layer and then passes through the zirconium phosphate layer. It should be understood that the upstream and downstream relationship is determined according to the flow direction of the liquid, the first flow is the upstream, and the later flow is the downstream, rather than the upper and lower relationship of the physical space. Generally, the adsorption column flows from bottom to top, so the downstream adsorption material is often in the upper layer.
[0167] In some conventional adsorption column structures, such as the adsorption column form disclosed in patent document CN106111079A, zirconium phosphate is mixed with urease to increase the pH buffering capacity through zirconium phosphate and reduce pressure by increasing the particle size of zirconium phosphate.
[0168] In addition, in the traditional Redy system, the pressure of the adsorption column will gradually increase during the treatment process, which will cause excessive pressure and threaten the stability of the adsorption column, dialysis equipment and dialysis system. Patent US9242036B2 fully mixes zirconium phosphate, urease particles and hydrated zirconium oxide layers, and adjusts the pressure and pressure drop by adjusting the size of the cation exchange particles. For another example, the filling structure of the adsorption column of the traditional regeneration system disclosed in patent document CN108025125A, the filling materials are mixed in a column in a layered manner, and the zirconium phosphate is downstream of the urease layer.
[0169] The adsorption column described in the present application is based on the above-mentioned prior art, and a portion of zirconium phosphate is placed upstream of the enzyme layer or metabolic cycle to specifically adsorb calcium and magnesium ions and reduce the formation of calcium carbonate and magnesium carbonate. In one embodiment, the adsorption column contains a zirconium phosphate layer upstream of the urease layer for adsorbing calcium and magnesium ions.
[0170] See also Fig.13 , which is a schematic diagram of the structure of the adsorption device of the present application in one embodiment. As shown in the figure, in this embodiment, the adsorption device contains two zirconium phosphate layers, one of which is located upstream of the urease layer, and the other is located downstream of the urease layer. In another embodiment, the adsorption device contains two zirconium phosphate columns, one of which is located upstream of the urease column, and the other is located downstream of the urease column.
[0171] In some embodiments, the dialysate regeneration circulation system includes a first adsorption device and a second adsorption device.
[0172] See also Fig.14 , which is a schematic diagram of the structure of the adsorption device of the present application in another embodiment. As shown in the figure, in this embodiment, the first adsorption device or the second adsorption device only contains zirconium phosphate.
[0173] See also Fig.15 , which is a schematic diagram of the structure of the adsorption device of the present application in another embodiment. As shown in the figure, in this embodiment, the first adsorption device or the second adsorption device is a mixed column containing zirconium phosphate, for example, a mixed column containing zirconium phosphate, hydrated zirconium oxide and activated carbon.
[0174] See also Fig.16 , which is a schematic diagram of the structure of the adsorption device of the present application in another embodiment. As shown in the figure, in this embodiment, the first adsorption device or the second adsorption device is a fully mixed column containing zirconium phosphate.
[0175] See also Fig.17, showing an implementation structure diagram of the adsorption device of the present application in the regeneration liquid circulation system. As shown in the figure, in this embodiment, the adsorption device contains at least two adsorption columns with zirconium phosphate, wherein the first adsorption device 61' is a column containing zirconium phosphate, and the first adsorption device 61' is located upstream of the metabolic cycle, and the other column containing zirconium phosphate is the second adsorption device 61", which is located downstream of the metabolic cycle. Alternatively, the first and second adsorption devices (61', 61") contain two fully mixed adsorption columns, both of which are fully mixed columns of zirconium phosphate, hydrated zirconium oxide and activated carbon, wherein one fully mixed adsorption column is located upstream of the metabolic cycle, and the other is located downstream of the metabolic cycle, wherein the composition of the adsorption materials of the two fully mixed adsorption columns is the same in proportion, and the filler amount or column size may be different.
[0176] In the Redy system and the traditional regeneration system, when the urea solution containing high concentrations of calcium and magnesium ions passes through the urease layer, the urea is decomposed into ammonium carbonate. At this time, the pH is between 8.5-9, and the calcium and magnesium ions are easy to form calcium carbonate and magnesium carbonate particles and precipitation with carbonate, thereby increasing the column pressure and reducing the activity of the enzyme and the local exchange efficiency. In the above-mentioned embodiment of the present application, the zirconium phosphate column located upstream is mainly used to adsorb calcium and magnesium ions, which helps to reduce the formation of calcium carbonate and magnesium carbonate particles in the urease layer or metabolic cycle, thereby stabilizing the pressure. The zirconium phosphate located downstream is mainly used to adsorb amine ions after urea decomposition. In the above-mentioned embodiment, the weight of the zirconium phosphate upstream is often less than the weight of the zirconium phosphate downstream. In some embodiments, this ratio is 3:6-3:7. In some embodiments, the zirconium phosphate upstream can be replaced with other cationic adsorption materials, such as cationic adsorption resins.
[0177] In certain embodiments, the adsorption device also includes a hollow fiber. The hollow fiber can repel positively charged ions and increase the capacity of the cartridge. The hollow fiber can be coated with an ion-repelling material that allows urea to pass through a mechanism similar to water purification, but repels positively charged ions, such as calcium and magnesium. The material coating the hollow fiber can be any such material known to those skilled in the art (e.g., fatty acids or polymer chains such as polysulfones), which can effectively repel calcium and magnesium, and thus retain ions in the dialysis solution. Typically, in order to produce this effect, the material itself will be positively charged. In certain embodiments, for example, the material for coating the hollow fiber is cellulose acetate (e.g., cellulose triacetate). The hollow fiber to be coated is commercially available, for example, Fresenius Medical Care North America, and can be coated with any desired ion-repelling material available to those skilled in the art.
[0178] Alternatively, hollow fibers can include ion-selective nanofiltration membranes. Such membranes are commercially available from many sources (e.g., Amerida, Koch, GE, Hoechst and Dow Chemical). The pore size of these membranes can prevent ionic species from diffusing through the membrane. For example, there are such nanofiltration membranes that can repel ions with multiple negative charges (e.g., sulfate and phosphate) while allowing singly charged ions to pass, and vice versa. In either case, hollow fiber devices can be obtained in various sizes, only needing to be small enough to fit into a replaceable, size-selectable cartridge for use in a home system.
[0179] In certain embodiments, the adsorbent cartridge may also include a flat membrane covered with a positively charged material as described above. In addition, the membrane may be an ion exchange (e.g., anion) membrane that restricts the passage of positively charged ions. Advantageously, the ion exchange membrane also has the ability to adsorb phosphate.
[0180] The cartridge and / or its components or layers can be replaced (e.g., membrane, urea degrading enzyme), regenerated (e.g., resin, adsorbent) and / or sterilized when needed (e.g., saturated, damaged, exhausted) to enable reuse. In addition, for example, when the regeneration efficiency of the cartridge decreases (e.g., due to layer saturation) or the cartridge becomes worn or damaged, the entire cartridge is replaceable and therefore can be removed from the dialysis system.
[0181] In another embodiment, the adsorption device includes a plurality of columns connected in series, wherein each column contains one or more adsorption materials. For example, columns containing potassium phosphate, hydrated zirconium oxide, and activated carbon materials are respectively connected in series. In this embodiment, one or more of a pressure sensor, a degassing device, and a pH sensor are provided between the plurality of columns connected in series.
[0182] In one embodiment, if Figures 1 to 8 The dialysate regeneration circulation system shown also includes an adsorption column bypass L2-6, one end of which is connected to the input end of the adsorption device 61, and the other end is connected to the output end of the adsorption device 61. A bypass valve 630 is provided on the bypass of the adsorption device 61.
[0183] In one embodiment, the zirconium phosphate and zirconium oxide in the adsorption device are separate modules and can be disassembled individually to facilitate treatment and regeneration (such as acid-base treatment) outside the system so that the zirconium phosphate and hydrated zirconium oxide materials can be reused.
[0184] In one embodiment, an ammonia sensor is provided between the adsorption device and the metabolic circulation module to detect the urea content of the liquid in the pipeline between the adsorption device and the metabolic circulation module. The ammonia sensor can calculate the urea content and the urea content treated by combining the added urease dosage and the action time, so as to form a module for online real-time detection and display of urea content and decomposition amount.
[0185] In one embodiment, if Figure 2 and Figure 3 As shown, the regeneration liquid pipeline L2-7 is provided with a sensor for detecting the content of urea and ammonia in the regeneration liquid pipeline L2-7. In this embodiment, a hydrophobic filter 6230 is provided between the ammonia sensor 6310 and the regeneration pipeline L2-7. In this embodiment, when the sensor for detecting the content of urea and ammonia in the regeneration liquid pipeline L2-7 detects that the ammonia content exceeds a preset value, an alarm device is made to output an alarm signal, and the control device 4 is made to conduct a second short-circuit valve 626' provided between the input end adjacent to the waste liquid passage L2-1 and the output end adjacent to the regeneration liquid pipeline L2-7, so that the liquid in the regeneration liquid pipeline L2-7 flows into the waste liquid passage L2-1 and participates in the metabolic cycle again.
[0186] The output end of the regeneration liquid pipeline L2-7 is provided with a regeneration liquid inlet valve 638, which is used to open or close the passage of the regeneration liquid to the dialyzer, or to the dialysis blood circuit, or directly input into the human body during peritoneal dialysis treatment. Specifically, the regeneration liquid inlet valve 638 can be a solenoid valve, a valve of an electric switch, or a clamp used to tighten the regeneration liquid pipeline L2-7 to close the circulation of the regeneration liquid.
[0187] In one embodiment, a bypass valve (such as Figure 2 and Figure 3 The second short-circuit valve 626' shown in the figure is used to short-circuit the waste liquid passage L2-1 and the regeneration liquid pipeline L2-7 when the bypass valve is opened.
[0188] In one embodiment, if Figure 2 and Figure 3As shown, the regeneration liquid pipeline L2-7 is provided with a concentrated liquid branch L2-8 for conveying concentrated liquid to the regeneration liquid pipeline L2-7, which is used to remove urea through the above-mentioned metabolic circulation device and remove other toxins through the adsorption device, and then replenish potassium, calcium and magnesium concentrated liquid through the concentrated liquid branch L2-8 to form dialysis waste liquid regeneration liquid, which is used again for dialysis treatment. In this embodiment, the concentrated liquid branch L2-8 is provided with a container 6320 (for example, a concentrated liquid bag) for storing concentrated liquid, and a concentrated liquid pump 6321 for conveying the concentrated liquid in the container 6320 to the concentrated liquid branch L2-8. The concentrated liquid includes potassium, calcium and magnesium concentrated liquid.
[0189] In one embodiment, a conductivity sensor 634 and / or a temperature sensor 635 is provided on the regeneration liquid pipeline L2-7 to detect the conductivity data and / or temperature data of the fluid in the regeneration liquid pipeline L2-7.
[0190] In the hemodiafiltration (HDF) mode, the regeneration fluid pipeline L2-7 of the dialysate regeneration circulation system of the present application is also provided with a replacement fluid branch L2-9, see Fig.18 and Fig.19 , Fig.18 Shown is a schematic diagram of the position of the replacement fluid branch of the hemodialysis device of the present application in the pre-dilution mode, Fig.19 The schematic diagram of the position of the replacement fluid branch in the post-dilution mode of the hemodialysis device of the present application is shown. As shown in the figure, one end of the replacement fluid branch L2-9 is connected to the regeneration fluid pipeline L2-7, and the other end is used to connect the dialysis circuit. In the embodiment where the dialysate regeneration circulation system is applied to a blood purification device, the output end of the replacement fluid branch L2-9 is used to connect the blood circuit of hemodialysis. In the embodiment where the dialysate regeneration circulation system is applied to a peritoneal dialysis device, the output end of the replacement fluid branch L2-9 is used to connect the peritoneal fluid circuit.
[0191] In one embodiment, the regeneration liquid pipeline L2-7 is provided with a first bacterial filter 633' for filtering bacteria in the regeneration liquid, and the first output end of the first bacterial filter 633' is connected to the output end of the regeneration liquid pipeline L2-7, and the second output end is connected to the replacement liquid branch L2-9. In this embodiment, the first bacterial filter 633' is a tangential flow filter or a filter in a dead-end filtration mode. The replacement liquid branch L2-9 is provided with a replacement liquid pump 650 for transporting the regeneration liquid to the dialysis circuit.
[0192] In another embodiment, a second bacterial filter 633" is provided on the replacement fluid branch L2-9 for filtering the dialysis regeneration fluid in the replacement fluid branch L2-9 again and then delivering it to the dialysis circuit.
[0193] In an embodiment, the replacement fluid branch L2-9 is used to divert the flow in the regeneration fluid pipeline L2-7 to balance the real-time dynamic balance in the dialysate regeneration circulation system.
[0194] The present application also provides a hemodialysis device for dialysis treatment, wherein the dialysis treatment includes the treatment of home dialysis treatment scenarios and hospital dialysis treatment scenarios.
[0195] See also Fig. 9 , which is a schematic diagram of the composition structure of the hemodialysis device of the present application in one embodiment. As shown in the figure, the hemodialysis device includes: a purification circuit (not shown), a dialysis device 64, a driving device 3, and a control device 4.
[0196] The connection mode and working principle of the dialysate regeneration circulation system are as described above for Figures 1 to 8 The methods described in each embodiment will not be repeated here. Among them, when the metabolic circulation device 60 of the dialysate regeneration circulation system is used, the enzyme-carrying microspheres added to the metabolic circulation pipeline L2-4 contain urease, and the urease decomposes urea to produce carbon dioxide and ammonia. A part of the generated carbon dioxide is dissolved in the liquid to form a buffer system, and a part may form gas, so that the liquid level of the collection container 600 in the metabolic circulation pipeline L2-4 drops. When the liquid level of the collection container 600 reaches the preset low level through the liquid level sensor 602, the three-way four-way valve or the flow channel switching device on the gas branch L2-5 is started to discharge the excess carbon dioxide. In the embodiment, the urea content in the blood is detected by detecting the pH, urea concentration or ammonia concentration of the metabolic circulation or metabolic circulation effluent, and the urea removal amount, the use of OCM or adsorbent are calculated, and displayed or prompted, and the enzyme activity is reacted or detected by comparing with the experience value or historical value, and the operator is prompted to add or replace the enzyme preparation.
[0197] When in use, enzyme-loaded microspheres can be added to the metabolic cycle, and the enzyme-loaded microspheres are circulated in the metabolic circulation pipeline L2-4 driven by the metabolic circulation pump. The treatment method is that the liquid to be treated containing a high concentration of target molecules enters the metabolic circulation pipeline L2-4 through the inlet, and the target molecules are decomposed into corresponding products by the enzyme-loaded microspheres. The metabolic filtration module continuously separates the treated liquid and retains the enzyme-loaded microspheres in the metabolic circulation pipeline L2-4. The treated liquid flows out of the metabolic circulation module through the metabolic filtration module.
[0198] The purification circuit includes a first circuit whose input end is connected to the first part of the human body, namely, the arterial blood circuit L1, and a second circuit whose output end is connected to the second part of the human body, namely, the venous blood circuit L3; the dialysate output end 641 is connected to the input end of the waste liquid passage L2-1 of the dialysate regeneration circulation system; the dialysate input end 640 is connected to the output end of the regeneration liquid pipeline L2-7 of the dialysate regeneration circulation system;
[0199] The driving device 3 is arranged on the first line and in the purification circuit, and is used to drive the fluid to flow in the purification circuit; in an embodiment, the driving device 3 includes but is not limited to a peristaltic pump, a pneumatic diaphragm pump, or a pressure pump, which is used to provide power to the fluid in the pipeline so that the fluid circulates in accordance with the preset flow direction. Here, in the application scenario for medical purposes, the driving device 3 should not directly contact the fluid, but only apply pressure to the pipeline and drive the fluid to flow. The preferred scheme of the driving device 3 is a non-contact pump device such as a peristaltic pump or a pneumatic diaphragm pump. More specifically, the peristaltic pump is, for example, a dialysis pump or a blood pump. The forward and reverse (reversal) of the peristaltic pump will cause the flow direction of the fluid in the circulation loop to be different. In the application example where the circulation loop is a waterway, the driving device 3 can be a contact driving pump, etc. to drive the fluid to flow forward or reverse in the circulation loop. In the application example where the circulation loop is a waterway, the driving device 3 can be a contact driving pump, etc. to drive the fluid to flow forward or reverse in the circulation loop.
[0200] It should be understood that the driving device 3 can drive the fluid in the pipeline at different positions in the pipeline, and its flow rate may change due to factors such as pipeline resistance, temperature, pressure, etc. in the direction of fluid flow. However, in the embodiment of the present application applied to the field of hemodialysis, the driving device 3 is arranged on the circulation loop, especially on the arterial blood line L1 of the purification loop.
[0201] The control device 4 is used to execute the treatment mode to purify the fluid flowing in the purification circuit and then input it into the human body. In an embodiment, the control device 4 is, for example, a controller or a system processor of a hemodialysis device, which outputs corresponding control instructions through a program written into the system processor; or receives a trigger instruction input by an operator to execute the relevant control instructions.
[0202] The hemodialysis equipment of the present application utilizes the dialysate regeneration circulation system. For example, a preparation containing enzyme-loaded microspheres can be added to the metabolic circulation device. The preparation is circulated in the circulation pipeline by the drive of the driving device. Specifically, the dialysis waste liquid to be treated containing a high concentration of target molecules enters the metabolic circulation device 60 through the inlet, and the target molecule preparation is decomposed into corresponding products. The metabolic filtration module 605 provided in the metabolic circulation device 60 continuously separates the treated liquid and retains the preparation in the metabolic circulation device. The treated liquid flows out of the metabolic circulation device 60 through the metabolic filtration module 605, and is then catalytically decomposed and adsorbed to produce dialysis regeneration liquid. After supplementing beneficial ions such as potassium, calcium, and magnesium in the regeneration liquid pipeline L2-7, it is used again in the dialysis process.
[0203] The hemodialysis equipment is a hemodialysis device including a hemodialyzer or a hemodiafiltration device. In an embodiment, the hemodialysis device includes a combination of one or more treatments of hemodialysis (HD), hemofiltration (HF), hemodiafiltration (HDF), hemoperfusion (HP), hemoexchange (PE), immunoadsorption (IA), or continuous blood purification (CRRT).
[0204] See also Fig.10 , shown as a schematic diagram of the composition structure of the hemodialysis equipment of the present application in another embodiment, as shown in the figure, the hemodialysis device also includes a dialysis device 64, which is used to purify the fluid flowing in the purification circuit, and the dialysis device 64 includes a dialysate output end and a dialysate input end. In an embodiment, the dialysis device 64 includes a dialyzer, and the dialyzer includes a dialysate chamber, a blood chamber and a semi-permeable membrane, etc., and the membrane separates the dialysate chamber and the blood chamber from each other. In the commonly used capillary dialyzer, the blood chamber is formed by the entire internal volume of the hollow fiber, and the dialysate chamber is formed by the inner cavity of the shell of the dialyzer surrounding the hollow fiber. In an embodiment, the top of the dialyzer is connected to the arterial blood line L1, and the bottom of the dialyzer is connected to the venous blood line L3.
[0205] The purification circuit of the hemodialysis device includes a first circuit, a second circuit, and a dialysate regeneration circulation system arranged between the first circuit and the second circuit for connecting the dialysis device. In an embodiment where the dialysis device is a hemodialysis device, the first circuit is an arterial blood circuit, and the second circuit is a venous blood circuit. Specifically, the purification circuit includes an arterial blood circuit L1 and a venous blood circuit L3 connected to the arterial blood circuit L1, and the purification circuit includes an arterial blood circuit L1 for accessing a first part of a human body (e.g., a human arterial blood vessel), a dialysis path connected to the arterial blood circuit L1, and a venous blood line L3 connected to the dialysis path, and the venous blood line L3 is used to access a second part of a human body (e.g., a human venous blood vessel); in some embodiments, such as when some patients have poor vascular conditions, such as single-needle dialysis or a PICC central venous catheter, the first and second parts of the human body may be the same part. Wherein, an air collecting chamber is provided on the venous blood line L3; the air collecting chamber is used to enrich the gas in the purification circuit when the fluid in the purification circuit flows from the venous blood line to the arterial blood line; in an embodiment, the purification circuit includes an arterial blood line L1, a dialysis access (the access including the dialysis device in the figure), and a venous blood line L3. Wherein, the arterial end 50 of the arterial blood line L1 and the venous end 90 of the venous blood line L3 are interconnected, so that the arterial blood line L1, the dialysis access, and the venous blood line L3 constitute a circulation circuit, namely a purification circuit. In the present application, the circulation circuit can be used as a pre-filling circuit in the pre-filling procedure; in the flushing procedure, the circulation circuit is also a flushing circuit; in the emptying procedure, the circulation circuit is also an emptying circuit.
[0206] In the treatment mode of the dialysis device, an arterial puncture needle is connected to the front end of the arterial blood line L1 through a connector, and a driving device such as a peristaltic blood pump is provided in the middle. On the other hand, a venous puncture needle is connected to the front end of the venous blood line L3 through a connector, and a drip chamber / venous pot or a gas collecting chamber having the function of a venous pot in the present application is connected in the middle. In addition, during dialysis treatment, the arterial puncture needle and the venous puncture needle are respectively punctured into the target arterial blood vessel and the target venous blood vessel of the patient's body. If the blood pump is driven, the patient's blood reaches the dialysis device through the arterial blood line L1, and then the blood is purified through the dialysis device, while debubbling is performed in the drip chamber / venous pot, and the blood is returned to the patient's body through the venous blood line L3. That is, the patient's blood is circulated from the front end of the arterial blood line L1 of the circulation loop to the front end of the venous blood line L3 in vitro, while the blood is purified through the dialysis device.
[0207] In some embodiments, the hemodialysis equipment includes one or more detection devices for detecting the concentration of target molecules in the dialysis waste fluid, detecting the content of enzyme-loaded microspheres in the waste fluid passage L2-1 (such as detecting the amount of enzyme-loaded microspheres added or whether they have been cleared), or detecting the content of enzyme-loaded microspheres in the regeneration fluid pipeline L2-7.
[0208] In some embodiments, the hemodialysis device further comprises a mode selection device, which is used to receive an input mode selection signal and send the determined working mode information to the control device to perform the operation corresponding to the working mode. In this embodiment, the working mode includes a combination of one or more treatment modes of HF treatment mode, HD treatment mode, HDF treatment mode, or / and ultrafiltration mode.
[0209] In one embodiment of the HF treatment mode, see Fig.11 , which is a schematic diagram of the composition architecture of the hemodialysis device of the present application in the pre-dilution mode. As shown in the figure, the control device 4 controls the regeneration fluid output by the dialysate regeneration circulation system to be directly input into the first line L1, such as the arterial pot 53. This mode of directly inputting the regeneration fluid into the arterial pot 53 can be called the pre-dilution mode.
[0210] In another embodiment of the HF treatment mode, see Fig.12 , which is a schematic diagram of the composition architecture of the hemodialysis device of the present application in the post-dilution mode. As shown in the figure, the control device 4 controls the regeneration fluid output by the dialysate regeneration circulation system to be directly input into the second line L3, such as the venous pot 93. This mode of directly inputting the regeneration fluid into the venous pot 93 can be called the post-dilution mode.
[0211] In the embodiment of the HD treatment mode, the control device 4 controls the regeneration fluid output by the dialysate regeneration circulation system to be input to the dialysate input end 640 of the dialysis device 64. Fig. 9 and Fig.10 The embodiment shown.
[0212] In the present application, the hemodialysis equipment can also realize the design of HDF treatment mode, that is, hemodiafiltration with dynamic control of the total amount of (circulating dialysate). In an embodiment, the total amount of liquid in the dialysate circulation is regulated by dynamically and periodically regulating the volume or liquid level of any container in the dialysate circulation, thereby achieving periodic filtration and filtration, and increasing the molecular convection exchange of the dialyzer.
[0213] like Fig.18As shown, in one embodiment of the HDF treatment mode, the control device 4 controls the regeneration fluid output by the dialysate regeneration circulation system to be input into the first circuit, such as the arterial pot 53, through the substitution fluid branch L2-9. This mode of directly inputting the regeneration fluid into the arterial pot 53 can be called a pre-dilution mode.
[0214] like Fig.19 As shown, in another embodiment of the HDF treatment mode, the control device 4 controls the regeneration fluid output by the dialysate regeneration circulation system to be input into the second line, such as the venous pot 93, through the substitution fluid branch L2-9. This mode of directly inputting the regeneration fluid into the venous pot 93 can be called a post-dilution mode.
[0215] exist Fig.18 or Fig.19 In the embodiment of the HDF treatment mode, the control device 4 dynamically adjusts the liquid volume in the waste liquid passage L2-1, the metabolic circulation device 60, or the regeneration liquid pipeline L2-7 periodically to adjust the output of the replacement liquid branch L2-9 to control the molecular convection exchange volume of the dialysis device 64. In one embodiment, the control device 4 dynamically adjusts the working cycle or power of the air pump in the metabolic circulation device 60 to adjust the liquid volume in the collection container 600 to adjust the output of the replacement liquid branch L2-9, thereby controlling the molecular convection exchange volume of the dialysis device 64.
[0216] In one embodiment, the control device periodically changes the total amount of liquid equilibrium state of the dialysate circulation to periodically filter and filter out the liquid inside and outside the dialyzer. In this embodiment, changing the total amount of liquid equilibrium state of the dialysate circulation is achieved by the control device periodically injecting or sucking air into or out of any container in the flow path to change the liquid volume of any container.
[0217] In one embodiment, in the HDF treatment mode, the total amount of the fluid equilibrium state of the dialysate circulation is changed by the control device periodically changing the volume of any container in the flow path, such as a collection container in the metabolic cycle, or the control device periodically expanding or reducing the volume of any flow channel, pipeline or container in the flow path.
[0218] In one embodiment, the Figure 3 As shown, in the HDF treatment mode, the total amount of liquid equilibrium state in the dialysate circulation is changed by adjusting the differential speed of the two dialysate pumps, the first dialysate pump 627' arranged in the waste liquid passage L2-1 and the second dialysate pump 627" arranged in the regeneration liquid pipeline L2-7.
[0219] The present application can realize the design of HDF treatment mode, i.e., hemodiafiltration with dynamic control of the total amount of (circulating dialysate) by setting gas branch L2-5 in the metabolic circulation device. The total amount of liquid in the dialysate circulation is controlled by dynamically and periodically regulating the volume or liquid level of any container in the dialysate circulation, thereby realizing periodic filtration and filtration, and increasing the molecular convection exchange of the dialyzer.
[0220] Please refer to Figure 7 As shown in the figure, assuming that the volume of the collection container 600 is about 20-30mL, the exhaust valve 6031, such as a four-way valve, can be connected to an air pump (6030', 6030") or a pressure sensor 6231" for degassing or aerating. Under standard conditions, the liquid level in the collection container 600 is at a low level, and the air is about 25mL. Due to the continuous injection of liquid into the dialysis waste liquid passage L2-1, the air chamber in the collection container 600 is at positive pressure.
[0221] In an embodiment, a HDF process can be divided into a plurality of identical cycles, or gas pumping or degassing cycles, by using Figure 7 In the embodiment shown, the liquid level and liquid volume in the collection container 600 are controlled by selectively controlling the first air pump 6030' or the second air pump 6030". In the degassing cycle (assuming 30 seconds), during the degassing process, the liquid level in the collection container 600 rises slowly, and the amount of water in the blood filtered to the dialysate side increases. If the degassing speed of the air pump is 46 ml / min, then the filtered water is 23 mL. In the gas filling cycle (assuming 30 seconds), the gas pressurized liquid level drops, and more dialysate is filtered into the blood at the same speed of 46 ml / min. That is, the increased filtration rate in one cycle (1 minute) is 23 mL, so the filtration volume in the entire treatment cycle of 240 minutes is 5.52 L.
[0222] In another embodiment of increasing the filtration volume, if the gas filling cycle is shorter than the degassing cycle, the gas filling speed is faster, for example, the gas filling is completed in 5 seconds, and the flow rate is 276ml / min; in this case, the time of one cycle is 35s, and the treatment time of 240min can work 411.4 cycles, and the total filtration volume is 9.45L.
[0223] In an embodiment of the ultrafiltration mode, the ultrafiltration branch L2-2 in the dialysate regeneration circulation system diverts the dialysate waste in the waste fluid passage L2-1 to increase the transmembrane pressure or negative pressure, so that the dialysis device filters an equal amount of liquid as the blood or peritoneal fluid passing through it into the dialysate waste, thereby achieving dehydration treatment.
[0224] In an embodiment of the ultrafiltration mode, the control device controls the rotation speed of the ultrafiltration pump or an empirical value to measure the flow rate of the dialysis waste liquid in the waste liquid passage L2-1 diverted by the ultrafiltration branch L2-2. For example, in one embodiment, the control device controls the rotation speed of the ultrafiltration pump by obtaining the volume or weight of the regeneration liquid in the regeneration liquid pipeline L2-7 to measure the flow rate of the dialysis waste liquid in the waste liquid passage L2-1 diverted by the ultrafiltration branch L2-2. For example, in another embodiment, the volume or weight of the regeneration liquid is obtained by weighing or liquid level measurement.
[0225] In an embodiment where the dialysate regeneration circulation system is applied to a blood purification device, for example in a hemodialysis treatment mode (HD), that is, a standard normal treatment mode, since the exchange between molecules is a free exchange driven by concentration difference, the purpose of exchange and toxin removal is achieved. Since an ultrafiltration branch L2-2 is provided on the waste liquid passage L2-1, simultaneous ultrafiltration dehydration can bring about an additional amount (e.g., 3-4L) of transmembrane flow.
[0226] In one embodiment, when the dialysate regeneration circulation system is applied to the circulation of a blood purification device, the ultrafiltration pump will continuously extract the water in the waste liquid passage L2-1 to form a transmembrane negative pressure. At this time, the dialyzer will ultrafilter more water to achieve pressure balance. Ultimately, the blood loses as much water as the ultrafiltration pump extracts, thereby achieving the purpose of dehydration. In an actual embodiment, the ultrafiltration pump continuously draws the dialysate waste in the waste liquid passage L2-1 into a waste liquid bag. By accurately measuring the flow rate of the ultrafiltration pump, the excess water in the patient's body can be accurately extracted from the body, thereby achieving the purpose of dehydration.
[0227] In another embodiment, the ultrafiltration branch L2-2 can also be arranged on the regeneration liquid pipeline L2-7, that is, the ultrafiltration branch L2-2 includes a first ultrafiltration branch and a second ultrafiltration branch, wherein the first ultrafiltration branch is arranged on the waste liquid channel, and the second ultrafiltration branch is arranged on the regeneration liquid pipeline L2-7. In this embodiment, weighing ultrafiltration control is adopted, that is, dual pump control of an upstream pump and a downstream pump is adopted, wherein the upstream pump is arranged on the first ultrafiltration branch, and the downstream pump is arranged on the second ultrafiltration branch in the regeneration liquid pipeline L2-7, and the second ultrafiltration branch is connected to the second ultrafiltration branch. The container connected to the filter branch, such as an ultrafiltration bag, contains treated dialysis regeneration fluid. There is a weighing device under the ultrafiltration bag. The weighing device can obtain the content of the regeneration fluid in the ultrafiltration bag by weighing, and adjust the speed of the upstream pump and the downstream pump by controlling the speed. For example, if the water in the ultrafiltration bag exceeds the preset value (ultrafiltration curve), it means that more water has been ultrafiltrated, so the speed of the upstream pump is lowered and the speed of the downstream pump is increased. On the contrary, if the water in the ultrafiltration bag is lower than the preset value (ultrafiltration curve), the speed of the upstream pump can be increased and the speed of the downstream pump can be lowered.
[0228] The present application also provides a peritoneal dialysis device for dialysis treatment, wherein the dialysis treatment includes the treatment of home dialysis treatment scenarios and hospital dialysis treatment scenarios. The peritoneal dialysis device includes a dialysate regeneration circulation system, a peritoneal dialysis pipeline, a driving device and a control device.
[0229] One end of the peritoneal dialysis pipeline is connected to the human peritoneal cavity, and the other end is connected to the dialysate regeneration circulation system; the peritoneal dialysis pipeline uses a single-pass catheter to periodically drain the accumulated fluid in the human peritoneal cavity and periodically introduce the dialysate regeneration fluid.
[0230] The driving device is disposed on the peritoneal dialysis pipeline and is used to drive the fluid to flow periodically in the peritoneal dialysis pipeline;
[0231] The control device is used to execute a treatment mode to periodically exchange fluid in the peritoneum of a human body.
[0232] The connection mode and working principle of the dialysate regeneration circulation system are as described above for Figures 1 to 8 The methods described in each embodiment will not be repeated here. Among them, when the metabolic circulation device of the dialysate regeneration circulation system is used, the enzyme-loaded microspheres added to the metabolic circulation pipeline L2-4 contain urease, and the urease decomposes urea to produce carbon dioxide and ammonia. A part of the generated carbon dioxide is dissolved in the liquid to form a buffer system, and a part may form gas, so that the liquid level of the collection container in the metabolic circulation pipeline L2-4 drops. When the liquid level sensor detects that the liquid level of the collection container reaches a preset low level, the three-way four-way valve or flow channel switching device on the gas branch L2-5 is started to discharge excess carbon dioxide. In the embodiment, the urea content in the blood is detected by detecting the pH, urea concentration or ammonia concentration of the metabolic circulation or metabolic circulation effluent, and the urea removal amount, OCM or adsorbent usage are calculated, and displayed or prompted, and the enzyme activity is reacted or detected by comparing with the empirical value or historical value, and the operator is prompted to add or replace the enzyme preparation.
[0233] When in use, enzyme-loaded microspheres can be added to the metabolic cycle, and the enzyme-loaded microspheres are circulated in the metabolic circulation pipeline L2-4 driven by the metabolic circulation pump. The treatment method is that the liquid to be treated containing a high concentration of target molecules enters the metabolic circulation pipeline L2-4 through the inlet, and the target molecules are decomposed into corresponding products by the enzyme-loaded microspheres. The metabolic filtration module continuously separates the treated liquid and retains the enzyme-loaded microspheres in the metabolic circulation pipeline L2-4. The treated liquid flows out of the metabolic circulation module through the metabolic filtration module.
[0234] The dialysis device of the present application adds a preparation such as enzyme-loaded microspheres to a metabolic circulation device, and the preparation circulates in a circulation pipeline through the drive of a driving device. The treated liquid is continuously separated out by a metabolic filtration module provided in the metabolic circulation device, and the preparation is retained in the metabolic circulation device. The treated liquid flows out of the metabolic circulation device through the metabolic filtration module, and is then catalytically decomposed and adsorbed to produce a dialysis regeneration liquid. After potassium, calcium and magnesium ions are supplemented in the regeneration liquid pipeline, the dialysis liquid is used again in the dialysis process, thereby solving the problems of low exchange efficiency in the existing perfusion mode, which increases the amount of enzyme used, and the loss of enzyme efficiency and safety risks due to enzyme shedding.
[0235] The above embodiments are merely illustrative of the principles and effects of the present application and are not intended to limit the present application. Anyone familiar with the technology may modify or change the above embodiments without violating the spirit and scope of the present application. Therefore, all equivalent modifications or changes made by a person of ordinary skill in the art without departing from the spirit and technical ideas disclosed in the present application shall still be covered by the claims of the present application.
Claims
1. A hemodialysis device, characterized in that: include: A purification circuit includes a first circuit having an input end connected to a first part of a human body, and a second circuit having an output end connected to a second part of the human body; A dialysis device, provided on the purification circuit, for purifying the fluid flowing in the purification circuit, the dialysis device comprising a dialysis fluid output end and a dialysis fluid input end; A waste liquid passage, an input end of which is connected to a dialysate output end of the dialysis device; A metabolic filtration module connected to the output end of the waste liquid passage, used for filtering out the metabolic treatment solution of the dialysis waste liquid after first toxin treatment of the mixed solution consisting of the dialysis waste liquid and the added enzyme or enzyme preparation or enzyme-loaded microspheres from the waste liquid passage; the metabolic filtration module includes a separation component to separate the metabolic filtration module into a first side for connecting to the waste liquid passage and a second side for filtering out the metabolic treatment solution of the dialysis waste liquid, and the enzyme or enzyme preparation or enzyme-loaded microspheres are retained on the first side; an adsorption device, the input end of which is connected to the second side of the metabolic filtration module, for performing a secondary toxin treatment on the metabolic treatment fluid of the dialysis waste liquid after the primary toxin treatment to generate a regeneration fluid; A regeneration liquid pipeline, whose inlet is connected to the adsorption device for outputting the regeneration liquid, and whose outlet is connected to the dialysate input end of the dialysis device or the first line or the second line; a driving device, provided on the first line and located in the purification circuit, for driving the fluid to flow in the purification circuit; The control device is used to execute a treatment mode to purify the fluid flowing in the purification circuit and then input it into the human body.
2. The hemodialysis device according to claim 1, characterized in that: The separation component is a porous membrane or a reverse osmosis membrane, wherein the porous membrane includes a microfiltration membrane, an ultrafiltration membrane, or a nanofiltration membrane; or, the separation component includes one or more of a flat membrane, a tubular membrane, a rolled membrane, a spiral membrane, and a hollow fiber membrane.
3. The hemodialysis device according to claim 1, characterized in that: The metabolic filtration module includes N sub-filtration modules, and the N sub-filtration modules are connected in series and / or in parallel with each other, wherein N is a positive integer greater than 2.
4. The hemodialysis device according to claim 3, characterized in that: The N sub-filtration modules are connected in series according to a connection order, and the average pore sizes or molecular retention capacities corresponding to the separation components of the N sub-filtration modules decrease in sequence.
5. The hemodialysis device according to claim 1, characterized in that: The dialysis device is a hemodialyzer or a hemodiafiltration device.
6. The hemodialysis device according to claim 5, characterized in that: The hemodialysis device includes one or more treatments selected from the group consisting of hemodialysis (HD), hemofiltration (HF), hemodiafiltration (HDF), hemoperfusion (HP), blood exchange (PE), immunoadsorption (IA), or continuous renal renal cell therapy (CRRT).
7. The hemodialysis device according to claim 1, characterized in that: It also includes at least one detection device for detecting the concentration of target molecules in the dialysis waste liquid, detecting the content of enzymes or enzyme preparations or enzyme-loaded microspheres in the waste liquid passage, or detecting the content of enzymes or enzyme preparations or enzyme-loaded microspheres in the regeneration liquid pipeline.
8. The hemodialysis device according to claim 1, characterized in that: It also includes a mode selection device, which is used to receive an input mode selection signal and send the determined working mode information to the control device to execute the operation corresponding to the working mode.
9. The hemodialysis device according to claim 1, characterized in that: The working mode of the hemodialysis device includes a combination of one or more treatment modes of HF treatment mode, HD treatment mode, HDF treatment mode, and / or ultrafiltration mode.
10. The hemodialysis device according to claim 9, characterized in that: In the HF treatment mode, the control device controls the output regeneration fluid to be directly input into the first circuit or the second circuit.
11. The hemodialysis device according to claim 9, characterized in that: In the HD treatment mode, the control device controls the output regeneration fluid to be input into the dialysate input end of the dialysis device.
12. The hemodialysis device according to claim 9, characterized in that: In the HDF treatment mode, the control device controls the output regeneration fluid to be input into the first circuit or the second circuit through the replacement fluid branch.
13. The hemodialysis device according to claim 12, characterized in that: In the HDF treatment mode, the control device adjusts the output of the replacement fluid branch by periodically and dynamically adjusting the fluid volume in the waste fluid passage, metabolic filtration module, or regeneration fluid pipeline to control the molecular convection exchange volume of the dialysis device.
14. The hemodialysis device according to claim 12, characterized in that: In the HDF treatment mode, the control device periodically changes the total amount of liquid equilibrium state of the dialysate circulation to periodically filter and filter out the liquid inside and outside the dialyzer.
15. The hemodialysis device according to claim 14, characterized in that: In the HDF treatment mode, the total amount of liquid equilibrium in the dialysate circulation is changed by the control device periodically injecting or sucking air into or out of any container in the flow path to change the liquid volume of any container.
16. The hemodialysis device according to claim 14, characterized in that: In the HDF treatment mode, the total amount of liquid equilibrium in the dialysate circulation is changed by periodically changing the volume of any container in the flow path through the control device.
17. The hemodialysis device according to claim 14, characterized in that: In the HDF treatment mode, the total amount of liquid equilibrium state in the dialysate circulation is changed by adjusting the flow rates set in the waste liquid passage and the regeneration liquid pipeline to change the total amount of liquid equilibrium state in the dialysate circulation.
18. The hemodialysis device according to claim 9, characterized in that: In the ultrafiltration mode, the ultrafiltration branch diverts the dialysis waste fluid in the waste fluid passage to increase the transmembrane pressure or negative pressure, so that the dialysis device filters an equal amount of fluid from the blood or peritoneal fluid flowing through into the dialysis waste fluid, thereby achieving dehydration treatment.
19. The hemodialysis device according to claim 18, characterized in that: In the ultrafiltration mode, the control device controls the rotation speed of the ultrafiltration pump or an empirical value to measure the flow rate of the dialysis waste fluid in the waste fluid passage diverted by the ultrafiltration branch.
20. The hemodialysis device according to claim 19, characterized in that: In the ultrafiltration mode, the control device controls the rotation speed of the ultrafiltration pump by obtaining the volume or weight of the regeneration liquid in the regeneration liquid pipeline to measure the flow rate of the dialysis waste liquid in the waste liquid passage diverted by the ultrafiltration branch.
21. The hemodialysis device according to claim 20, characterized in that: The volume or weight of the regeneration liquid is obtained by weighing or liquid level measurement.
Citation Information
Patent Citations
Hemodialysis system having a flow path with a controlled compliant volume
CN103889481A
Blood purification system and method for adsorbing blood waste
CN112206365A
Recirculating dialysate fluid circuit for blood measurement
US20170112991A1
Fluid treatment method, and cycle treatment device and system
WO2022036739A1
Cited By
Integrated pipeline consumable device for blood purification
CN121338149A
Dialysate temperature measuring system and method, temperature control system and hemodialysis machine
CN122440918A
